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The specific and timely degradation of proteins is achieved by the Ubiquitin-Proteasome
System (UPS), which governs a variety of cellular processes such as apoptosis, cell cycle
progression, protein quality control, and metabolism. Using this system, cells maintain
homeostasis by quickly and irreversibly altering signaling pathways in response to changing
environmental stimuli. Protein degradation by UPS requires two consecutive steps, 1) the
covalent attachment of the substrate by ubiquitin and 2) the delivery of the substrate to the 26S
proteasome for breakdown and recycling of reusable ubiquitin. The 26S proteasome is a 2.5MDa multicatalytic protease consisting of two subcomplexes: a 20S core particle (CP) and a 19S
regulatory particle (RP) that caps one or both ends of the 20S proteasome. Most investigations on
proteasome regulation have focused on substrate recognition, binding, deubiquitination,
unfolding, and translocation. However, evidence shows that the 26S complex itself can be
regulated by the abundance of available subunits, rates of assembly and disassembly, posttranslational modification, localization, and a variety of interacting proteins. Yet, this data is
limited and an extensive amount of knowledge remains to be uncovered regarding 26S
proteasome regulation since it differs depending on the tissue and cellular context. Aging, for
example, leads to reduced proteasome activity but it is unknown how proteasomes are affected
throughout the aging process.
In this thesis, the aim is to reveal how proteasomes are regulated by changes in
nicotinamide adenine dinucleotide (NAD+) metabolism and how this impacts neurodegeneration.

Using Drosophila melanogaster, I describe the necessity for the proteasome regulator, DmPI31,
in neuronal maintenance and show that dietary restriction and NAD+ repletion, can regulate both
DmPI31 and proteasome activity. Generation of dmPI31 mutant clones in the Drosophila eye
show rapid degeneration of photoreceptor cells and RNAi knockdown of DmPI31 leads to
eclosion defects and shortened lifespan. I demonstrate the ability of NAD+ repletion to increase
proteasome activity and DmPI31 protein levels and show NAD+ acts via DmPI31 to increase
26S proteasome activity. The importance of this pathway is illustrated by the finding that
elevated levels of DmPI31 can extend lifespan and partially rescue neuronal degeneration in a
Drosophila model of spinocerebellar ataxia type 1(SCA1). These results demonstrate a link
between NAD+ and proteasomes that may ultimately prove useful for developing interventions
that counter the effects of neurodegeneration and allow for an understanding why this system
begins to fail in aging and age-associated diseases.
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1. Introduction

1.1 Protein Degradation by the Ubiquitin-Proteasome System (UPS)
1.1.1 The Ubiquitin-Proteasome System
The concept of a tightly controlled and highly regulated mechanism for intracellular protein
degradation was until a few decades ago underappreciated by many scientists. Now, the dynamic
state of the proteome, by regulated synthesis and degradation, are recognized as being crucial for
diverse cellular processes. The two major pathways of protein degradation in eukaryotic cells are
the lysosomal proteolysis pathway and the ubiquitin-proteasome system (UPS). Lysosomal
proteolysis is a bulk process that involves the uptake of extracellular proteins, cytoplasmic
organelles, or cytosolic proteins into membrane bound vesicles that will fuse with the lysosome.
Once inside these membrane-bound organelles, engulfed proteins are exposed to several
digestive enzymes that will non-selectively degrade them at approximately the same rate. In this
way, long lived cytoplasmic proteins are eventually degraded. The degradation of short-lived
intracellular proteins however is primary conducted by the UPS. This system requires proteins to
be tagged with a chain of an evolutionarily conserved polypeptide termed ubiquitin via a highly
regulated enzymatic cascade. These polyubiquitinated proteins are then targeted for delivery to
the multisubunit protease complex termed the proteasome. Both the attachment of ubiquitin and
degradation of proteins by the proteasome are energy dependent processes that require ATP
(Glickman and Ciechanover, 2002; Nedelsky et al., 2008). It was the discovery of this intricate
cascade and the targeted degradation of proteins that transformed the field. It is now clear that
targeted protein degradation plays a major role in a variety of cellular processes such as
1

apoptosis, cell cycle progression, differentiation, DNA repair, protein quality control, and
metabolism. However, much remains to be learned about the regulation of protein degradation
by the UPS. Uncovering mechanisms that regulate proteasomal degradation under varied cellular
contexts and determining how aberrations in this process bring about disease leave much to be
discovered.

1.1.2 Composition of the UPS
The UPS is a selective pathway that degrades cytoplasmic and nuclear proteins. It requires
two consecutive steps 1) the covalent attachment of the substrate by ubiquitin and 2) the delivery
of the substrate to the 26S proteasome for breakdown and recycling of reusable ubiquitin.
Ubiquitin (Ub) is a highly conserved 76-amino acid polypeptide that is attached to lysine
residues to form polyubiquitin chains on proteins targeted for degradation by the 26S proteasome.
Conjugation of ubiquitin usually occurs at lysine residues and requires 3 types of enzymes: E1
(ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin ligase).
Ubiquitin is activated in an ATP dependent manner by the E1 activating enzyme, which
generates a high-energy thiol ester intermediate. Next, one of several E2 conjugating enzymes
receives the ubiquitin from E1 and forms a similar thiol ester intermediate before binding to one
of many E3 ubiquitin ligases. From here the E3 ubiquitin ligase binds to a specific substrate and
catalyzes the transfer of ubiquitin from the E2 enzyme to the substrate. E3 ubiquitin ligases thus
hold the key to substrate specificity in the UPS. The subsequent addition of ubiquitin to lysine
residues on previously conjugated enzyme forms the polyubiquitin chain that is recognized by
the 26S proteasome (Glickman and Ciechanover 2002; Hershko and Ciechanover 1998).

2

After tagging with ubiquitin, proteins are targeted to the 26S proteasome. This complex is a
sophisticated 2.5-MDa multicatalytic protease consisting of two subcomplexes: a barrel shaped
20S core or catalytic particle (CP) and a 19S regulatory particle (RP) that caps one or both ends
of the 20S proteasome. Both subcomplexes are made up of distinct subunits. The 20S CP is made
from the stacking of two identical outer alpha rings and two identical inner beta rings, each of
which has seven distinct subunits. The N-terminal tails of the alpha subunits form a “gate” into
the center of the core where the proteolytic beta subunits reside. The beta subunits, beta1, beta2,
beta5, contain the three distinct catalytic functions, caspase-like, trypsin-like, and chymotrypsinlike activity, respectively, so named due to the types of peptides they generate. These active sites
are located deep within the barrel of the narrow entrance channel, 13 Å, thus proteins must be at
least partially unfolded for translocation into the core particle prior to degradation (Groll et al.,
2000). The 19S RP is important for translocation of proteins into the CP but also functions in the
recognition of ubiquitinated proteins and deubiquitination of substrates. It is composed of a base
with three non-ATPases (Rpn1, Rpn2, Rpn13), six ATPases (Rpt1-6) and a lid with nine nonATPase subunits (Rpn3, Rpn5-9, Rpn11-12, Rpn15) and Rpn10, which is assumed to sit between
the interface of the base and the lid (Murata et al., 2009). The six ATPases are responsible for
gate opening and facilitating substrate entry. The C-termini of the six ATPase subunits contain a
three-residue HbYX (Hydrophobic-tyrosine-X) motif that upon ATP binding allows for docking
of these subunits into the pockets between the alpha subunits of the 20S CP to promote gate
opening (Smith et al., 2007a). Subunits of the base including Rpn1, Rpn13, Rpt4, and Rpn10
sequester ubiquitinated proteins directly or through intermediaries that contain both ubiquitinlike domains (UBL) and ubiquitin-associated domains (UBA). The only subunit with a known
biochemical function in the lid is Rpn11, which facilitates de-ubiquitination of substrates to
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further their degradation (Coux et al., 1996, Glickman and Ciechanover, 2002). The other
functions of the lid subunits remain elusive.

Figure 1.1 Structure and function of the UPS
Two steps are critical for degradation of substrates by the proteasome. First, substrates must be tagged
with ubiquitin (ub), a 76 aa polypeptide. This involves three distinct classes of enzymes, E1, E2, and
E3s, that work in concert to attach distinct ub chains. The ub-activating enzyme, E1, uses ATP to
activate ub before transfer to the E2, ub-conjugating enzyme. The last step involves the E3 ub-ligase
that takes ub and typically links it to a lysine residue on the target substrate. The specificity of
degradation comes from E3 ub-ligases which are abundant and recognize one or a few specific
protein motifs. After ubiquitination, substrates are targeted to the proteasome for degradation. The
majority of active proteasomes reside as 26S proteasomes which are formed from the attachment of
the 20S CP with the 19S RP. This complex works to recognize, deubiquitinate, unfold, and
translocate substrates into the proteolytic barrel for cleavage. However, alternative activators exist
such as the 11S and PA200 that support hydrolysis of small peptides. Due to the abundance of
proteasome substrates, the proteasome is involved in a variety of cellular processes such as quality
control, cell cycle, and signal transduction. Figure is adapted from (Vilchez et al., 2014).
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1.1.3 Regulation of the UPS
The regulation of the ubiquitin proteasome system can occur at the level of substrate
ubiquitination and/or at the level of proteasome activity. Much of the earlier studies focused on
regulation at the level of substrate ubiquitination. Protein substrates can be monoubiquitinated,
multiubiquitinated, or polyubiquitinated and how each of these contributes to various cellular
processes is being actively investigated. The attachment of ubiquitin to lysine residues gives
flexibility to branching in the formation of polyubiquitin chains. This branching is highly
regulated and results in different physiological processes such as protein degradation by the
proteasome when ubiquitin is attached to Lys-48 and modification of signal transduction when
attached to Lys-63 (de Bie and Ciechanover, 2011). However, it is now obvious that proteasomes
themselves can be regulated by alternative activators, various interacting proteins, translational
control, and post translation modifications. Currently, the direct regulation of proteasome activity
is not well understood probably owing to tissue and context-specific regulators. Although the
primary proteasome machinery found in eukaryotic cells is composed of the 20S CP and 19S RP
to form the 26S holoenzyme, the population of proteasomes in any given cell may be
heterogeneous. For instance, many 20S CP can be capped on one side by the 19S RP and a
different complex, e.g., PA28, on the other. Impairment or failure of the UPS leads to defects in
the proteostasis network often resulting in diseases such as cancer and neurodegeneration, thus
properly assembled proteasomes directed to the appropriate locales are a necessity. Since
proteasomal degradation is required for numerous cellular functions, the regulation of
proteasome activity must be delicately and specifically tuned to meet the needs of specific cells
at a given moment. Due to its role in modulating a variety of different cellular outcomes the UPS
has arisen as an attractive target for the development of therapeutics. The drug Bortezomib is the
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first therapeutic proteasome inhibitor to be used in humans. It is used to treat multiple myeloma
by preventing proteasome mediated degradation of proapoptotic proteins and many times is
given in combination therapy to overcome drug resistance (Chen et al., 2011). A major side
effect that occurs in 30% of patients on Bortezomib is peripheral neuropathy and suggests that
synapses may be particularly sensitive to proteasome inhibition (Alé et al., 2015). Studying how
the UPS is regulated can aid in the development of effective treatments for a variety of diseases
and provide clues as to how these diseases may develop.
1.1.3.1 Alternative activators of the proteasome
The most common and often referred to as “default” activator of the proteasomes is the
19S core particle. This activator is ATP dependent and mostly mediates the degradation of
ubiquitinated substrates. However, alternative activator complexes and alternative catalytic
subunits exist that can regulate the activity of the proteasome as well. There are three well
known alternative activators that can replace or work in concert with the 19S RP: PA28 (also
known as REGα,β or 11S), REGγ and PA200/Blm10. PA28 is composed of two homologous
subunits PA28α and PA28β that in vitro form a heptameric ring that stimulates the hydrolysis of
small peptides by the 20S. Unlike the 19S cap, PA28 lacks ATPase activity and ubiquitin
binding ability. It is thought to optimize MHC class I presentation and is upregulated in response
to interferon γ stimulation (Cascio et al., 2002). REGγ shares a similar size to PA28, both being
heptameric assemblies that have no ATPase activity or ubiquitin-sensing receptors to support
unfolding of proteins, however is not induced by interferon γ. It has been reported to degrade key
cell cycle inhibitors such as p21, p19, p16 and the regulatory protein steroid receptor coactivator3 (SRC-3) in a ubiquitin and ATP-independent manner. This alternative regulator is
overexpressed in some cancers and linked to defects in mitosis and apoptosis (Li et al., 2006; Liu
6

et al., 2013) . The third activator PA200/Blm10 is a large protein that binds to the CP as a
monomer but takes on a circular shape (Schmidt and Finley, 2013). Blm10 again does not utilize
ATP and is thus implicated in hydrolyzing peptides. It is suggested to act as an adaptor that
functions under circumstances of hybrid proteasomes and is reported to have a role in a wide
variety of processes such as spermatogenesis, DNA repair, mitochondrial inheritance, and
possibly 20S assembly (Savulescu and Glickman, 2011; Stadtmueller and Hill, 2011). One study
has also reported Blm10 to be necessary for sequestering 20S CP into proteasome storage granuli
(PSG) during quiescence in yeast (Weberruss et al., 2013). Fairly recently, CDC48/p97 has also
been described as a proteasome activator that binds to the 20S CP in archaea. CDC48 is a AAA+
ATPase that contains a HbYX domain much like the Rpt base subunits of the 19S and can bind
to the 20S CP, induce gate opening, unfolding of substrates, and ultimately result in degradation
(Barthelme and Sauer, 2012). Since many alternative activators may be transiently associated,
context specific, or substoichiometric it is likely that with the advancement of tools more
proteasome activators will be discovered.

1.1.3.2 Transcriptional Regulation
Transcriptional control is another means by which proteasome activity can be regulated.
Proteasome subunits are thought to reside within cells only in relation to their respective their
respective complexes, 19S or 20S, with the exception of Rpn10/S5a which has been found in a
free state (Piterman et al., 2014). However, studies on the basal rate of proteasome subunit
biosynthesis are lacking. Under stress however, proteasome subunits undergo a coordinated
upregulation pointing to common signaling pathways regulating their gene expression (Livneh et
al., 2016). Proteasome inhibition is reported to cause upregulated proteasome synthesis across
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several species from humans to Drosophila. The two most well studies transcription factors
involved are the mammalian Nrf1/Nrf2, orthologs of C. elegans SKN-1, and Rpn4 in yeast. In
mammals, Nrf1 is found bound to the endoplasmic reticulum but in response to partial
proteasome inhibition, it is processed and translocated to the nucleus. Here, it results in the
transcription of all 26S subunits as well as CDC48/p97 (Sha and Goldberg, 2014). Nrf2 is similar
to Nrf1 as they both recognize a common promoter element, antioxidant response element
(ARE), in the genes they control. However, they differ in their regulation and subcellular
localization, with Nrf2 being mitochondrial and then cytoplasmic upon induction. Also, from
knockout studies in mice it is clear that Nrf1 plays a role in development while Nrf2 is important
for response to oxidative stress and protection from neurodegeneration (Schmidt and Finley,
2013). In yeast, Rpn4 is a short-lived protein that is quickly degraded by the proteasome.
However, when proteasome activity is comprised Rpn4 levels accumulate and this protein acts as
a transcription factor, binding to PACE (proteasome associated control elements) sequences
upstream of proteasomal subunits. In this way Rpn4 is under negative feedback control and acts
as a sensor for impaired proteasome biogenesis. Additionally, RPN4 gene transcription can be
induced by Hsf1, under heat stress, Yap1, during oxidative stress, and Pdr1/3, during drug
resistance. Thus, these conditions promote proteasome biogenesis through upregulation of Rpn4.
Upregulation of single proteasome subunits has also been shown to coordinate the
upregulation of other subunits and proteasome activity itself. For instance, upregulation of the b5
subunit acts in a number of human cell lines to increase proteasome assembly and subsequent
activity. This upregulation was shown to protect cells from oxidative stress by leading to higher
degradation rates (Chondrogianni et al., 2005). Similarly, upregulation of Rpn6 under the
transcriptional control of DAF-16/FOXO4 in C. elegans and humans, was shown to elevate
8

proteasome activity. This did not coincide with global proteasome subunit upregulation but is
instead thought to enhance activity by accelerating the association between 20S and 19S particles
(Pathare et al., 2012; Vilchez et al., 2012). Conversely, upregulation of the 26S proteasome
subunit S5b via the TNFα/NFkB inflammatory signal is reported as an inhibitor of 26S activity
by interfering with assembly. Interestingly, overexpression of S5b resulted in shorten lifespan
and onset of aging phenotypes in mice while Drosophila mutants for S5b show rescue of tau
induced rough eye and prolonged lifespan in tauopathy (Shim et al., 2012). These results show
that proteasome regulation is complex, context dependent, and may be differentially controlled
between cell types and species.
1.1.3.3 Proteasome associated proteins
Proteasome activity is required for a wide variety of cellular process with demands that
may change depending upon tissue type, nutrient availability and developmental stage. Thus, in
addition to the core proteasome subunits, proteasomes are associated with a wide variety of
proteasome interacting proteins (PIPs). Several PIPs have been found to be involved in efficient
assembly of proteasomes in mammalian cells such as p28, s5b, and p27 (Heinrichs, 2009).
However, weakly associated or transiently associated factors that may have essential roles may
prove difficult to identify. Additionally, the use of different purification techniques can cause the
number of PIPs identified to range from 24 putative interactors (Verma et al., 2000) to a network
of more that 471 proteins (Guerrero et al., 2008). The functions of these proteins vary and
include E3 ligase activity, shuttling of ubiquitinated substrates to the proteasome, DUB activity,
altered proteasome stability, and inhibition of the 20S CP. Although most PIPs are found at
substoichiometric amounts, a few including Ecm29 are reported to be co-regulated with
proteasome subunits and found at nearly the same levels. This protein, which is found
9

exclusively in the cytosol (Tai et al., 2010), is also shown to bind and stabilize the interaction
between 20S and 19S particles (Leggett et al., 2002; Tai et al., 2010) and preferentially
associates with mutant proteasomes (De La Mota-Peynado et al., 2013). Recent reports have
shown the Ecm29 can inhibit proteasome-mediated protein degradation and disassemble the 26S
proteasome in response to oxidative stress (Wang et al., 2017). Although the exact mechanisms
are still under investigation, this protein likely functions to ensure that abnormal proteasomes
remain inactive.
Numerous studies have also demonstrated the association of neuronal proteins with the
proteasome. Parkin, an E3 ubiquitin ligase, is capable of activating 26S proteasomes via its Nterminal ubiquitin-like domain which enhances association with 19S subunits. Interestingly,
mutations in parkin are linked to early-onset familial Parkinson’s disease (PD) and proteasome
dysfunction (Um et al., 2010) implicating an essential role for proteasome activity in maintaining
healthy neurons. Moreover, constituents of aggregates in PD namely a-synuclein and amyloid
beta (Ab) interact with the proteasome and inhibit UPS function in vitro and in vivo (Chen et al.,
2006; Gregori et al., 1995; Snyder et al., 2003; Stefanis et al., 2001) indicating a role for
proteasome dysfunction in the progression of PD.
Another group of PIPs in the brain, identified by mass spectrometry in the rat cortex, are
the 14-3-3 family members g, z, and d. In general, 14-3-3 protein family members have a broad
range of functions in the brain stemming from their known interaction with over 200 proteins.
They participate in cell signaling, cell cycle, apoptosis and neural development. Interestingly,
some isoforms are enriched within the synapse to regulate transmission and plasticity. In concert
with this is the finding that the phosphobinding protein14-3-3g is only found on synaptic
proteasomes (Tai et al., 2010) and presumably regulates protein turn over at synapses. Another
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14-3-3 family member, 14-3-3z, binds to PA28, a proteasome activator, and suppresses
proteasome assembly and increases sensitivity of multiple myeloma cell lines to proteasome
inhibition (Gu et al., 2018). Unpublished results from our lab by Dolors Ferres-Marco also
indicate 14-3-3z plays a role in proteasome inhibition and showed that this protein modulates
proteasome-mediated dendritic pruning of sensory neurons during development.
Last, interacting proteins can regulate proteasome activity by localizing proteasomes to
areas of proteolytic demand. This is especially true in neurons where cell bodies can be up to a
meter away from sites of synaptic activity in the axon, where proteasomes are needed. Recently,
the Drosophila homolog of the LC8 dynein light chains, Cut up (Ctp), was shown to interact
with 19S and 20S proteasome subunits in motor neurons of Drosophila 3rd instar larvae. This
interaction facilitates the transport of proteasomes and it was found to be independent of synaptic
vesicle proteins. This report shows that proteasomes also exhibit more anterograde movement
than retrograde and mutations in ctp severely affect transport leading to an increase in the
number of satellite boutons (Kreko-Pierce and Eaton, 2017). These studies demonstrate a critical
need for proteasome regulation at the synapse and show that defects in proteasome localization
lead to irregular synapse formation and function.

1.1.3.4 Posttranslational modifications
Several posttranslational modifications can modify proteasome activity. More than 345
modifications of 11 different types were shown to associate with the yeast 26S proteasome with
many sites being a target for more than one modification. This indicates that communication
between post-translational modifications may regulate proteasome activity (Hirano et al., 2016).
Many of the functional consequences of these post-translational modifications have not been
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identified. Of interest to this thesis are posttranslational modifications that have been identified
to alter proteasome function in response to metabolic changes. These modifications point to
pathways that might alter proteasome activity depending on nutrient availability and the
metabolic status of the cell. In Drosophila, 26S proteasomes are modified by O-linked N-acetyl
glucosamine (O-GlcNAc) that inhibits proteasome activity (Sümegi et al., 2003). O-GlcNAc
transferase (OGT) adds the O-GlcNAc moiety to the Rpt2 subunit of the 19S cap, specifically
affecting the ATPase activity of the proteasome and leading to an inhibitory affect. Yet another
example of metabolically regulation proteasome function is through Protein kinase A (PKA)
phosphorylation. PKA activity is dependent on cyclic AMP (cAMP) levels in the cell. Using
purified 26S proteasomes it was shown that 26S proteasome activity is enhanced via PKA
phosphorylation of Rpt6, an AAA+ ATPase located in the 19S regulatory cap (Zhang et al.,
2007a). Lastly, the Steller lab has shown another potential mechanism by which proteasomes are
metabolically regulated. This mode of regulation does not directly target a proteasomal subunit
but instead targets the PIP, PI31. TNKS is shown to mediate the ADP-ribosylation of PI31which
reduces its binding affinity for 20S a subunits. The model predicts that this modification relieves
20S repression thus promoting 26S assembly. The necessity for ADP-ribose subunits links this
pathway to metabolism since these subunits are derived from intracellular nicotinamide adenine
dinucleotide (NAD+) pools (Cho-Park and Steller, 2013). NAD+ is a metabolite for a variety of
cellular processes and redox reactions within the cell but also acts as a substrate for NAD+
consuming enzymes such as poly ADP-ribose polymerases (PARPs) like TNKS. The role of
NAD+ in regulating proteasome activity will be explored in this thesis and the neuroprotective
function of NAD+ discussed in a later section.
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1.1.4 DmPI31 is an essential proteasome regulator
An essential regulator of proteasome activity was identified in a screen for defective
caspase activation in Drosophila spermatogenesis. A novel F-box protein termed nutcracker, that
is the ortholog of mammalian FBXO7, was isolated and shown to interact with SkpA and Cullin1, components of an Skp/Cullin/F-box (SCF) ubiquitin ligase complex. Nutcracker mutants are
defective in caspase activation and proteasome activity (Bader et al., 2010). A biochemical
screen for proteins interacting with Nutcracker identified DmPI31. It was shown that nutcracker
binds to DmPI31 via a conserved Fbxo7/PI31 (FP) domain and stabilizes DmPI31 (Bader et al.,
2011; Chu-Ping et al., 1992). DmPI31 is homologous to mammalian PI31, a 31kD proline rich
protein, which was initially isolated as an inhibitor of 20S proteasomes. DmPI31 shares over
45% homology with mammalian PI31 proteins. The interaction between these proteins was
shown to be necessary for caspase activation, proteasome activity and ultimately
spermatogenesis in Drosophila. Although, PI31 was initially found to be an inhibitor of 20S
proteasomes in vitro that competes with PA28 for binding (Chu-Ping et al., 1992), (Zaiss et al.,
1999) in vivo activation of DmPI31 stimulated proteasome activity and rescued proteasome
defects. Loss-of-function studies in Drosophila result in defects in protein breakdown further
defining the role for DmPI31 in stimulating proteasome function. Thus, DmPI31 serves as an
activator of the 26S proteasome and its activity is essential for normal protein breakdown and
organismal survival. This protein is also shown to be an activator of 26S proteasomes while
inhibiting 20S proteasomes in vitro. DmPI31 mutants also display reduced proteasome activity
and lethality during the 3rd instar larvae to pupal transition (Bader et al., 2011). The full activity
of DmPI31 is dependent on the HbYX motif located at its C-terminus. This motif is shared by
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other modulators of proteasome activity such as the AAA+ ATPase Rpt subunits of the 19S
proteasome and CDC48/p97.
In search for regulators of DmPI31 activity, TNKS, an ADP-ribosyltransferase, was
identified as a direct binding partner that modulates PI31 activity through ADP-ribosylation.
TNKS is a member of the PARP superfamily of proteins and it widely known for its role in
binding the negative regulator of telomere length, TRF1. It localizes to many subcellular
locations including telomeres, spindle poles, and the cytoplasm and several binding partners of
TNKS have been identified that containing an RXXPDG motif or a degenerate form, including
PI31. Similarly, the ADP-ribosylation of PI31 by TNKS is shown to be necessary as TNKS
inhibition decreases proteasome activity in vivo. ADP-ribosylation of PI31 blocks the binding of
PI31 to the a subunits of the 20S proteasome and thus relieves 20S inhibition by PI31.
Additionally, ADP-ribosylation promotes the binding of dp27 and dS5b to PI31, which
sequesters them from the 19S RP to promote 26S assembly. The C-terminal HbYX motif is
required for DmPI31 binding to TNKS and the assembly chaperones dp27 and dS5b (Cho-Park
and Steller, 2013). These data provide a mechanism by which PI31 acts as a regulator of
proteasome assembly that is potentially under metabolic control (Figure 1.2).
Native gel analysis shows that recombinant GST tagged PSMF1/PI31 can form trimers,
hexamers, and nonamers. In silico modeling of PSMF1/PI31 predicts that this protein may form
a heptameric ring that binds to the 20S in replacement of the 19S RP and inhibits substrate entry
into the 20 CP (Clemen et al., 2015). In vitro, PI31 was shown to bind 26S proteasomes but has
no effect on activity nor did PI31 overexpression or RNAi cause cellular proteasome defects.
However, this paper also reports that the 10 -22 residue C-terminal peptides of PI31 can activate
20S hydrolysis in a HbYX dependent manner but that the C-terminus of PI31 itself inhibits the
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20S CP. Interesting, the N-terminus of PI31 alone does not shown any inhibition of 20S CP
suggesting that PI31 can regulate proteasome activity via its C-terminal tail mediating gate
opening (Li et al., 2014).

Figure 1.2 Current Model for Increased Proteasome Assembly by ADP-ribosylation of PI31
The current model for increased proteasome activity by ADP-ribosylation of PI31 shows that TNKS uses
NAD+ as a donor for ADP-ribose groups. TNKS directly binds to PI31 to transfer ADP-ribose and this
binding requires the HbYX domain of PI31. This model predicts that PI31 sits on the 20S CP blocking the
entry chamber but that upon ADP-ribosylation of PI31, 20S binding is relieved and PI31 binding to 19S
chaperones increases. These two events allow the 20S and 19S to come together more efficiently under
conditions that require increased 26S proteasome activity. Figure adapted from (Cho-Park and Steller,
2013).

How DmPI31 interacts with the proteasome to regulate its function is still unclear given the
difference between activities in vitro and in vivo. An Arabidopsis homologue of PI31, named
proteasome regulator 1 (PTRE1), was shown to be a positive regulator of 26S proteasomes and
mediates auxin suppression of proteasome activity. Mutations in ptre1 result in severe
developmental defects in plants and auxin is thought to mediate proteasome activity by altering
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PTRE1 localization (Yang et al., 2016). Unpublished data from our lab by Kai Liu also indicate
that DmPI31 functions as a modulator of proteasome localization. However, whether PTRE1
interacts with other proteins or undergoes post-translational modifications requires further
investigation. The yeast ortholog of PI31, Fub1, was shown to co-immunoprecipitate with both
the 20S and 26S proteasome but not free 19S particles. Fub1 also shows an inhibitory effect on
20S in vitro but did not show any inhibitory effects on proteasome degradation in vivo. In fact,
neither deletion not overexpression of Fub1 in vivo had any deleterious effects on proteasome
function. It was only when DFub1 was combined with deletion of a 20S assembly chaperone,
Dpba4, did lethality occur and this lethality could be rescued by Da3, a CP subunit, or deleteion
of the N-terminal of Da7 (Yashiroda et al., 2015). However, the generation of alternative
proteasome complexes, where deleted subunits can replace others, complicates the interpretation
of Fub1 function in vivo. Thus, an understanding of the structure of PI31 interaction with 20S
and 26S proteasome in vivo will elucidate its role in regulating proteasomes.

1.2 Protein homeostasis in neurodegeneration
In late-onset neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and
Huntington’s disease there is an accumulation of ubiquitin conjugated aberrant proteins into
aggregates in the brain. These aggregates often show accumulation of chaperones and
proteasome subunits suggesting that UPS activity was initiated but proteasomes fail to degraded
these proteins. For instance, defining traits of AD include the accumulation of
Ab neurite plaques and tau containing neurofibrillary tangles. These protein aggregates can also
be seen in the brain during the normal aging process suggesting an important role for cellular
degradation systems in the clearance of proteotoxic aggregates during aging (Gray et al., 2003).
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A possible explanation for the accumulation of toxic proteins and subsequent aging phenotypes
is the impairment of the UPS. Indeed, many reports describe a decrease in proteasome activity in
aged organisms. This decrease has been associated with altered expression of proteasome
subunits and impairment in proteasome assembly (Dasuri et al., 2009; Rogers et al., 2012;
Vernace et al., 2007; Vilchez et al., 2014). Loss-of-function mutations that result in decreased
proteasome activity also shown enhance neurodegenerative phenotypes. Mutations in FBXO7,
the mammalian homolog of Drosophila nutcracker that binds to and stabilizes DmPI31, was
found to cause early onset Parkinsonian-pyramidal disease (PPD) (Di Fonzo et al., 2009) FBXO7
was shown to interact with the PSMA2/alpha2 subunit of the proteasome and modifies it via
ubiquitination. Additionally, mutations in Parkin, a ubiquitin ligase, lead to a failed interaction
between this protein and its substrate a-synuclein resulting in the formation of Lewy bodies and
eventually in familial PD. Parkin expression is also downregulated in AD and may contribute to
accumulation of intracellular Ab (Zheng et al., 2016). Spinocerebellar ataxia type 3 (SCA3) is a
polyglutamine disorder caused by the CAG expansion of in the gene encoding Ataxin-3. Ataxin3 itself if a DUB containing a ubiquitin interacting motif that when overexpressed in Drosophila
can protect from polyQ induced neurodegeneration (Winborn et al., 2008). Another member of
the ataxia family of neurodegenerative disorders is that of Spinocerebellar ataxia-type 1 (SCA1).
This polyQ disease is caused by a CAG repeat in the gene product, ataxin-1. In this model,
proteasome activity has been shown to be directly impaired by decreased degradation of a shortlived fluorescent protein (Park et al.). Modifier screens have been conducted in Drosophila
models of both SCA1 and SCA3 to look for suppressors of neurodegeneration. In these studies
the role for proper protein folding and protein degradation are highlighted as the majority of
modifiers fell into the chaperone or UPS category.
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1.2.1 Role of the UPS in Wallerian degeneration
Wallerian degeneration is the result of damage to nerve fibers that can be seen early on in
diseases such as Alzheimer’s, Parkinson’s, and multiple sclerosis. It occurs in response to
infections, diabetes, and normal aging. The Wallerian degeneration slow mouse (wlds) is an
autosomal dominant genetic alteration that encodes for the first 70 amino acids of the
ubiquitination factor Ufd2a and full length Nmnat1. It shows resistance to nerve cell damage
both in vitro and in vivo. Overexpression of Nmnat1, an enzyme that catalyzes that last step in
NAD+ biosynthesis, has been shown to protect axon degeneration induced by transection in the
dorsal root ganglion neurons (Mack et al., 2001). The protection seen in the wlds mouse could be
a result of protecting NAD+ levels since depletion of NAD+ and ATP is accompanied with
axonopathy. This protection of NAD+ provides a possible role for proteasomes in the protection
of axon degeneration due to TNKS mediated ADP-ribosylation of PI31. PARP-1 inhibitors may
also play a role in protection from neuronal death. Excessive activation of PARP-1 leads to the
depletion of cytosolic NAD+ which has been linked to PARP-1 mediated neuronal cell death.
Reports have shown that the induction of DNA strand breaks in PARP-1-/- neurons saves
cytosolic NAD+ levels and rescues neuronal death. In addition, replenishing NAD+ levels in
neurons that have suffered DNA damage can prevent PARP-1 induced neuronal death (Alano et
al., 2010). Thus, the beneficial effects of NAD+ in neuronal protection may in part be related to
the ADP-ribosylation of PI31 and subsequent proteasome assembly.

1.2.2 Age-associated decline in proteostasis
In Drosophila melanogaster, aging is associated with a decline in proteasome activity and
this appears to be due to reduced assembly of the 26S proteasome (Tonoki et al., 2009). Aged

18

flies show an accumulation of ubiquitinated proteins and a decline in the level of 26S proteasome
protein compared to young flies. This age-related reduction in 26S proteasomes can be overcome
with the overexpression of Rpn11, a component of the 19S RP known for its de-ubiquitinating
activity. The overexpression of this subunit also suppresses the accumulation of polyubiquitinated proteins with age, increases fly lifespan, and rescues SCA3 induced
neurodegeneration (Tonoki et al., 2009). Another recent study in Drosophila showed that
impairment of the proteasome with the feeding of proteasome inhibitors promoted the aging
phenotype and reduced lifespan. However, this study uncovers a proteasomal regulatory circuit
that upregulates proteasome mRNAs and subunits in response to impaired proteasome
functionality. This upregulation is dependent on Nrf2, which is a transcription factor that is
traditionally known for its role in mediating responses to oxidative stresses (Tsakiri et al., 2013).
Additional evidence for a critical role for proteasomes in aging comes from studies of
elevated proteasome activity. In such a study conducted in Saccharomyces cerevisiae, UPS
capacity was manipulated with the use of the Rpn4 transcription factor. Cells deleted for RPN4
show a decrease in proteasome levels, while loss of the ubiquitin ligase that regulates Rpn4
turnover, UBR2, upregulates Rpn4 and thereby increases in proteasome components. The
replicative life span in this yeast model was significantly extended with increased UPS capacity
while a decrease in UPS capacity shortens replicative life span. In yeast models for
neurodegenerative diseases, a loss of UBR2 results in improved clearance of toxic huntingtin
fragments suggesting that increased proteasome capacity prolongs lifespan through the
elimination of toxic proteins (Kruegel et al., 2011).
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1.2.3 Proteasome transport to the synapse
Efforts to identify the causes and mechanisms underlying neurodegenerative diseases
have undoubtedly uncovered defective proteostasis as a major cause for the progression of
neurodegeneration. However, whether the various types of toxic aggregates lead to progressive
impairments in proteostasis that only manifest in disease overtime or whether some other factors
play a role is still a major question. AD is of major interest since it is the most common brain
degenerative disorder and begins with impairments in cognitive function that prevent the
formation of new memories followed by progressive loss of previously encoded memories. Since
patients at the early stages have intact motor and sensory neurological function it is suggested
that failure at the synapses required to form new memories are the cause. Although Ab plaques
and tau tangles are hallmarks of the disease, early studies report dysfunction at the synapse as the
initial target of AD. Indeed, deficits in a number of neurotransmitters accumulate with disease
progression and loss of synapses correlate more robustly to cognitive decline than the number of
Ab plaques or tau tangles (Selkoe, 2002). This poses the question of how proteostasis is
maintained at the synapse under physiological conditions. Many studies have shown a
requirement for the UPS to maintain synaptic plasticity and that proteasome activity is distinctly
regulated at the synapse (Hamilton and Zito, 2013; Tsai, 2014). One way in which proteasome
activity is regulated here is by transport of proteasomes from the cell body to the synapse and
within different synaptic compartments such as the dendritic shaft to dendritic spines. Both 19S
and 20S proteasomes are previously described as being trafficked into dendritic spines upon
activity and this is correlated with an increase in degradation of polyubiquitinated proteins in
spines. Theses proteasomes are shown to be tightly associated with the actin cytoskeleton
suggesting proteasomes can be actively transported to subcellular localizations where protein
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degradation is needed (Bingol and Schuman, 2006). Since then several reports have established
proteasome association with molecular motors and support the hypothesis that proteasomes
move both anterograde and retrograde to carry out local degradation to maintain synapses (Otero
et al., 2014; Hsu et al., 2015; Kreko-Pierce and Eaton, 2017). Evidence of local dysfunction in
proteasome degradation results in early phases of tauopathies and the formation of ubiquitin
conjugated tau aggregates (Tai et al., 2012). Thus, mechanisms that disrupt the transport of
proteasomes to axons could initially lead to synaptic dysfunction which compounds overtime and
leads to neurodegenerative phenotypes.

1.2.4 Neuroprotective role of NAD+ metabolism
Nicotinamide adenine dinucleotide (NAD+), it phosphorylated form (NADP+) and
reduced forms (NADH and NADPH) have crucial roles in processes such as transcription, cell
cycle control, DNA repair, and metabolism. There are two major pathways via which cells
produce NAD+, the de novo pathway that uses tryptophan and the NAD+ salvage pathway that
recycles nicotinamide and nicotinic acid from the diet. This molecule serves as a substrate for
three classes of enzymes: poly (ADP-ribose) polymerases (PARPs), cADP-ribose synthases, and
Sirtuins. PARPs are NAD+ consuming enzymes that produce an ADP-ribosyl protein
modification and/or form ADP-ribose polymers. The addition of each unit of ADP-ribose to an
acceptor protein requires one molecule of NAD+ creating a considerable challenge for cellular
NAD homeostasis when ADP-ribosylation is activated. One of the major causes of cell death due
to genotoxic stress is the hyperactivation of PARP-1, which depletes cytoplasmic and nuclear
NAD+. The depletion of NAD+ also results in the inability for a cell to generate ATP, which is a
major requirement for 26S proteasome mediated degradation. cADP-ribose synthases, CD38 and
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CD157, are ectoenzymes that use NAD+ as a substrate to generate second messengers, such as
cADP-ribose, which contributes to calcium mobilization. Sirtuins are enzymes whose function to
deacetylate lysine residues of transcription factors and histones is dependent on the
NAD+/NADH redox ratio. These enzymes have emerged in the regulation of cell survival and
longevity. Specifically, Sir2 has been shown to mediate lifespan expansion in S. cerevisiae,
C.elegans, and D. melanogaster (Belenky et al., 2007). Recent studies have shown that genetic
or pharmacological inactivation of the PARP1 homolog, pme-1, in C. elegans increases NAD+
pools and extends lifespan through sir-2.1, the worm sirtuin homolog, and boosts mitochondrial
metabolism (Mouchiroud et al., 2013).
The therapeutic potential of NAD+ metabolism is well recognized, as pathophysiological
states such as neurodegeneration can be suppressed by increasing NAD+ production or
associated enzymes. For instance, overexpression of Nmnat1 in dorsal root ganglion (DRG)
neuronal explant cultures protected axons from both mechanical transection, ischemia, and
toxins such as vincristine (Araki et al., 2004, Coleman and Perry, 2002 )(Gillingwater et al.,
2004). The addition of exogenous NAD+ 24 hours prior to axonal transection also delays axonal
degeneration although this protection is less effective than lentiviral expression of Nmnat1
(Araki et al., 2004). It was also found that degenerating axons show a decrease in NAD+ levels
and protection of this NAD+ pool efficiently protects axons from degeneration (Wang et al.,
2005). Overexpression of Nmnat has also been shown to suppress tauopathy by reducing the
number of hyperphosphorylated tau oligomers. This protection is independent of its NAD+
synthase activity and was shown that Nmnat can directly interact with phosphorylated tau and
promote its ubiquitination and clearance (Ali et al., 2011). Drosophila models of spinocerebellar
ataxia 1 (SCA1) showed that both Nmnat as well as an enzymatically inactive form of Nmnat are
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neuroprotective. This study found that Nmnat acts independent of its NAD+ synthase activity
and instead acts as a chaperone for neuronal maintenance and protection (Zhai et al., 2008).
NAD+ levels vary significantly between tissues and are dramatically altered by dietary levels of
nicotinic acid and nicotinamide (Belenky et al., 2007; Elhassan et al., 2017). Dietary niacin has
shown to confer protection from the development of AD and cognitive decline (Morris et al.,
2004). Recent data has found that the reduced form of NAD+, NADH can directly bind 26S
proteasomes via a putative binding motif found on 19S subunits. Interestingly, addition of 0.1 or
0.5 mM NAD+ to NIH3T3 cells increased the levels and activity of 26S proteasomes. This was
likely due to increased assembly as there was no change in proteasome subunit expression
(Tsvetkov et al., 2014). In Drosophila pink1 mutants, increasing the NAD+ salvage pathway via
supplementation of nicotinamide prevents neurodegeneration and rescues mitochondrial defects
(Lehmann et al., 2017). This precursor was also shown to ameliorate mitochondrial dysfunction
and motor deficits in a Drosophila model for PD (Jia et al., 2008). These findings point to a
pathway that may link neuroprotection, NAD+, and the proteasome. The exact mechanisms by
which Nmnat and NAD+ confer neuroprotection and whether they are independent of each other
remain to be determined.
Dietary Restriction (DR) without malnutrition was first describe by McCay et al. in 1935 to
extend mean and maximal lifespan of rats and since then its beneficial effects have been
described as reducing cancer incidence and delaying the onset of aging phenotypes. Interestingly,
DR increases intracellular NAD+ levels (Guarente and Picard, 2005) providing yet another
connecting to possible regulation of proteasome activity via DmPI31. DR is thus far the only
non-genetic way in which to increase lifespan in every model organism studied from primates to
yeast. Many hypotheses for how dietary restriction contributes to longevity have been proposed
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such as enhancement of apoptosis, increased physical activity, reduced metabolic rate,
attenuation of insulin IGF-1 signaling, and protein turnover (Xiang and He, 2011). In yeast,
dietary restriction was shown to extend replicative lifespan through a mechanism that was
dependent on Sir2 and Npt1, a nicotinic acid phosphor-ribosyltransferase. Interestingly, NAD+
salvage pathway proteins and nicotinamide induced NAD+ increase can mediate neuroprotection
and longevity (Lin et al., 2000; McClure et al., 2012; Ocampo et al., 2013).

Figure 1.3 NAD+ de novo synthesis and salvage pathways in Drosophila
NAD+ is an essential coenzyme crucial for a variety of cellular processes, redox reactions, and cellular
respiration. It is also the substrate for three major classes of enzymes, sirtuins, cADPRs, and PARPs.
NAD+ can be synthesized from the aa tryptophan via de novo synthesis or from dietary intake of
metabolites Na and Nam via the NAD+ salvage pathway. Byproducts of NAD+ digestion are recycled
back into useful forms by enzymes in the salvage pathway, available enzymes in flies are indicated in red
with CG number. NMNAT is essential for neuronal health and mammals have 3 genes corresponding to
different subcellular localization while flies have one gene, CG13645. This salvage pathway is also
essential in humans as lack of dietary metabolite intake results in the vitamin deficiency disease pellagra.
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1.3 Relevance
The therapeutic potential of NAD+ metabolism is well recognized, as pathophysiological
states such as neurodegeneration can be suppressed by increasing NAD+ production or
associated enzymes. Additional data shows that TNKS mediated ADP-ribosylation of PI31,
which requires NAD+ can promote 26S proteasome assembly. Natural aging may predispose to
neurodegeneration as both proteasome assembly and NAD+ are shown to decline with age in
worms and mice (Tonoki et al., 2009, Mouchiroud et al., 2013, Gomes et al., 2013, Yoshino et
al., 2011, Ramsey et al., 2008). Both of these findings suggest a mechanism by which declining
NAD+ levels can cause decreased proteasome activity and lead to the progression of age
associated neurodegeneration. The overarching aim is to bridge metabolic and genetic
mechanisms of proteasome regulation to expand the scientific body of knowledge on how
proteolysis impacts aging and neurodegenerative diseases. Understanding protein degradation
during the progression of neurodegeneration and the regulators involved will uncover potential
therapeutic targets to delay the onset of these diseases. This thesis will address the role of
DmPI31 in Drosophila neurons during development and in maintaining neuronal health in
addition to studying how NAD+ metabolism influences PI31 mediated proteasome activity.
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2. Characterization of DmPI31 in neuronal maintenance and longevity

2.1 Summary
Neuronal remodeling and maintenance are processes that require a tight balance between
protein synthesize and degradation. The UPS mediates proteolysis in neurons in a highly
regulated fashion by tagging specific proteins with ubiquitin and targeting them to the
proteasome for degradation. Proteasomes are regulated in a diverse manner through interactions
with alternative activators, post-translational modifications, and changes in localization. This
chapter characterizes the role of a proteasome-interacting protein, Drosophila PI31 (DmPI31),
within neurons of both larvae and adult flies. This protein is shown to localize to distinct brain
regions where it co-expresses with proteasome subunits. Generation of mitotic clones mutant for
dmPI31 revealed that this protein is essential for protein degradation in adult photoreceptor
neurons, as these cells accumulate poly-ubiquitinated proteins and rapidly degenerate. Targeted
RNAi-mediated knockdown of PI31 in neurons resulted in eclosion and motor neuron defects
further suggesting an essential role for DmPI31 in neurons. Lastly, the crucial role of regulating
expression of this protein is shown as a result of its impact on Drosophila lifespan. Together,
these results uncover previously unknown roles for DmPI31 in the Drosophila nervous system.

2.2 Rationale
In a screen for regulators of caspase activation during Drosophila spermatogenesis, a
proteasome regulatory complex composed of nutcracker and DmPI31 was found to be necessary
for proper sperm differentiation. Nutcracker interacts with and promotes DmPI31 stability and
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together they participate in non-apoptotic caspase activation that drives cellular remodeling in
the testes. DmPI31 mRNA transcripts are highly expressed in the testes while females and
mutants lacking germline cells express reduced amounts (Bader et al., 2011). However, dmPI31
mutants display pupal lethality suggesting a role for this protein outside of the testes as well.
Initially reported as an inhibitor of 20S proteasomes in vitro, PI31 has a conserved HbYX (Hb=
Hydrophobic amino acid, Y = Tyrosine, and X= any amino acid) motif shared by Rpt subunits
for binding or activation of 20S proteasomes (Smith et al., 2007b; Kumar et al., 2010). Indeed,
DmPI31 was shown to function in vivo as a proteasome activator that can rescue the dominantnegative temperature sensitive proteasome alleles DTS5 and DTS7, mutations in subunits B2 and
B5 respectively. The HbYX motif at the C-terminal tail of DmPI31 is necessary for full
proteasome activation but deletions in this region still manage to increase 26S proteasome
activity in vitro and in vivo (Bader et al., 2011). However, knowledge on the in vivo role of
DmPI31 outside the testes is lacking. Similar to sperm, neurons go through periods of cellular
remodeling where proteolysis must play a critical function.
In this chapter, I explore the role of DmPI31 in neuronal function by characterizing the
localization of this protein as well as associated mutant phenotypes. The localization of
proteasomes within neurons plays a key role in regulating protein degradation during processes
such as dendritic pruning, synaptic plasticity, and neuronal maintenance (Wójcik and DeMartino,
2003; Janse et al., 2004; Patrick, 2006). Endogenous PI31 displays both cytoplasmic and nuclear
localization but expresses more highly the central brain of 3rd instar larva. In adult flies, DmPI31
localizes to a subset of neurons in the central brain as well as photoreceptor axons. Using loss of
function mutants and driving RNAi of PI31 in specific neuronal subtypes, I show that PI31 is
essential for neuronal maintenance. Polyubiquitinated proteins accumulate, neurons rapidly
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degeneration, and the number of active zones is reduced. These studies clarify the role of
DmPI31 as a proteasome activator in vivo and illustrate the importance of PI31 in neuronal
maintenance.

2.3 Results
2.3.1 DmPI31 is expressed in the Drosophila central brain and adult photoreceptor axons
It was reported that the majority of adult DmPI31 mRNA resides in the testes (Bader et al.,
2011). However DmPI31 mRNA is present at low levels in the adult female and is expressed
throughout the Drosophila life cycle (Arbeitman et al., 2002). Furthermore, mass spectrometry
from an enriched membrane fraction of adult Drosophila heads identified DmPI31 along with
other proteasome subunits (Aradska et al., 2015) confirming the presence of DmPI31 in locales
beyond the testes. In order to determine the role of DmPI31 in neuronal function, I explored the
expression and localization of this protein in the brains of 3rd instar larval and adult flies. To
probe for the localization of this protein in vivo, I took advantage of a transgenic line expressing
a mCherry-DmPI31 fusion protein driven by the endogenous promoter for DmPI31
(PI31::mCherry-PI31). This fusion protein was previously shown to properly localize in the
testes and to rescue mutant phenotypes (Bader et al., 2011). Confocal z-stack images of 3rd instar
larval brains show that DmPI31 is highly expressed in the central brain (CB) and ventral nerve
cord (VNC) relative to the optic lobes (OLs) (Figure 2.1). Both the larval CB and VNC contain
large neural stem cells termed neuroblasts that are multipotent and generate the neuronal and
glial diversity in the adult central nervous system (CNS) (Egger et al., 2008; Homem and
Knoblich, 2012). Proteasome function has been reported to play a crucial role in neuroblasts and
neurogenesis. Mutations in the 19S proteasome subunit Rpn10 show strong mitosis defects in
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larval neuroblasts (Szlanka et al., 2003) while Prosb21, a dominant temperature-sensitive
mutation (DTS5) in the b2 subunit of the 20S proteasome, caused mild mitotic defects in these
cells (Neuburger, 2006). To determine whether DmPI31 is specifically localized to larval
neuroblasts, I stained PI31::mCherry-PI31 larval brains with the neuroblast markers deadpan
(Dpn), which marks the nuclei of large neuroblasts, and prospero (Pros), which marks the
smaller nuclei of ganglion mother cells (GMCs). Although DmPI31 is fairly ubiquitous in the
CB, Dpn positive cells show a higher expression of DmPI31 in the CB compared to Pros positive
cells (Figure 2.2a). Proteasome expression levels within the larval brain were determined by
assaying the expression of a GFP-tagged a2 subunit under the endogenous promoter since
proteasome subunits are rarely found as single components. a2-GFP is ubiquitous but highly
expressed in the perinuclear region of the neuroblasts and cytoplasm. This protein is also seen to
localize to the cytoplasm of neural progeny (Figure 2.2b). To determine whether DmPI31 colocalizes with the proteasome in neuroblasts, flies expressing GFP-tagged a2 or Rpt3 subunits
under their endogenous promoters (Ma et al., 2002) were crossed to PI31::mCherry PI31 lines.
Confocal z-stacks of 3rd instar larval brains were analyzed and showed more expression of
DmPI31 within a2 and Rpt3 positive cells (Figure 2.2c,d). However, not all a2GFP expressing
cells showed elevated PI31 indicating that this protein is actively regulated depending upon the
cellular state. Both a2GFP and Rpt3GFP display nuclear and cytoplasmic localization consistent
with previous reports on proteasome localization in Drosophila (Ma et al., 2002) although Rpt3
has a broader cytoplasmic expression pattern (Figure 2.2d). The increase in expression of these
subunits within neuroblasts may be attributed to proteasome demand being higher in actively
dividing cells (Wójcik and DeMartino, 2003). To determine DmPI31 localization in the adult
brain, whole-mount brain dissections from age matched PI31::mCherry-PI31 adults were fixed
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alongside Oregon-R brains to control for background fluorescence(Figure 2.3a). The expression
pattern of DmPI31 in the central brain is consistently localized to a specific subgroup of cells in
the central brain that is yet unexplored (Figure 2.3b,c). I cannot rule out that these neurons are
undergoing apoptosis or PE remodeling and thus show upregulated DmPI31 that may suggest
upregulate proteasome activity. However, mcherry-PI31 additionally localizes to the R7 and R8
photoreceptor axons found in the adult medulla (Figure2.3d-e). This localization points to the
possibility that DmPI31 is being actively transported to axons, since these axons project a fair
distinct from their cell bodies. Visualizing the outermost axon terminals shows high levels of
PI31 expression overlapped with the cell specific marker for the R7/R8 axons (Figure 2.3f)
providing further evidence to support the idea that PI31 is transported to these distal locations.
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Figure 2.1 DmPI31 expression is highly localized to the central brain and ventral nerve
cord in 3rd instar larval CNS
(a) Schematic of 3rd instar larval central nervous system. Central brain (CB), ventral nerve cord
(VNC), optic lobe (OL), outer proliferation center (OPC), inner proliferation center (IPC),
neuroblasts in optic lobe and central brain (NB), medulla (me), neuroepithelium (NE), lamina
furrow (LF). (b-f) Ventral view of confocal z-stack projections of 3rd instar larval brains
expressing PI31-mCherry fusion protein under the PI31 endogenous promoter. (b) Composite
image shows DmPI31 expression in red relative to neural progenitors marked by anti-deadpan
(Dpn) in green, neural progeny labeled with anti-prospero (Pros) in white and DAPI in blue
labelling nuclei. (c) Endogenous PI31 expression localizes to the CB and VNC where its
expression is higher in large cells, called neuroblasts, marked by anti-Dpn. (d) anti-Dpn staining
marking neural progenitors in the CB and VNC. (e) anti-Pros staining marking the neural
progeny in a stereotype fashion that does not overlap with anti-Dpn. (f) DAPI staining shows
nuclei of all cells in the CB, OL, and VNC. (g-k) Dorsal view of the larval CNS. (g) Composite
confocal projection showing DmPI31 expression from the dorsal side overlapping with anti-Dpn
in green and with anti-Pros in white. (h) Endogenous mCherry-PI31 (i) anti-Dpn (j) anti-Pros (k)
DAPI. All images are shown at 20X magnification.
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Figure 2.2 DmPI31 and proteasome subunits co-express in the central brain of 3rd instar
larval CNS
(a-d) Confocal z-stack projections show the CB and OL at 63X magnification. (a) mCherry
tagged PI31 is expressed ubiquitously in the CNS but more notably in the nucleus and cytoplasm
of large neuroblast cells in the CB. Confocal z-projections show the specific staining pattern of
anti-Pros (white), anti-Dpn (green), PI31(red), and DAPI (blue). (b) The alpha2-GFP tagged
subunit of the 20S proteasome is expressed in the cytoplasm and perinuclear region of the
neuroblasts. This protein is also seen to localize to the cytoplasm of neural progeny. The
composite image shows alpha2-GFP (green), anti-Pros (white), anti-Dpn (red), and DAPI (blue).
(c) 3rd instar larval brains co-expressing both endogenous mCherry-PI31(red) and endogenous
alpha2-GFP (green) a 20S proteasome subunit. Brains were stained with anti-Dpn (purple)
marking neuroblast nuclei and Dapi (blue) staining all nuclei. The vast majority of neuroblasts
express both PI31 and alpha2GFP however there are a few exceptions (white arrows). (d) 3rd
instar larval brains co-expressing both endogenous mCherry-PI31 and endogenous RPT3-GFP, a
19S regulatory subunit. RPT3 is highly expressed in the cytoplasm and perinuclear region of the
neural progenitors as well as in the cytoplasm of neural progeny along with PI31.
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Figure 2.3 DmPI31 expresses within the adult CNS
(a-e) Confocal z-stack projections at 20x magnification of whole-mount adult Drosophila brains.
(a) Wildtype brains show the mCherry background signal along with DAPI staining. (b) DmPI31
expresses in a stereotyped fashion in a subset of neurons. (c) A similar pattern of neuronal
expression is seen within a different set of optical sections in a separate brain. (d) Optic lobe
image of wildtype flies labeled with DAPI. (e and e’) Optic lobe images show high expression of
mcherry-PI31 in the R7/R8 medulla axons at 20X and (e’) 63X. (f) Z-stack projections at 63X of
the optic lobe medulla show PI31(red) highly expressed in the R7/R8 axon terminals labeled
with anti-chaoptin (white).
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2.3.2 DmPI31 mutants display mitotic defects and accumulate polyubiquitinated proteins
DmPI31 was found to cause accumulation of polyubiquitinated proteins and cell-cycle
defects in the male-germline (Bader et al., 2011). However, whether DmPI31 functions in a
similar manner in neuronal tissue is unknown. To learn more about the function of DmPI31, I
stained brains from dmPI31 mutants which survive into the pupal stage, for the presence of
polyubiquitinated proteins (FK2), an apoptosis marker (Dcp-1), and the cell cycle factor (cyclin
B). Since heterozygous mutants for dmPI31 are viable and show no obvious phenotype, it is
expected that proteasomes are not impaired and thus this line was used as a control for FK2
staining. However, FK2 did not show an accumulation in dmPI31-/- larval brains compared to the
dmPI31-/+ (Figure 2.4a’,b’). It is possible that the impairment of proteasomes activates a
compensatory degradation machinery, such as autophagy, in these cells that acts to degrade any
accumulated proteins (Lőw et al., 2013; Nedelsky et al., 2008). To determine whether there was
increased apoptosis in these mutants, I stained for cleaved Dcp-1, the active form of a critical
effector caspase. A slight accumulation of cleaved DCP-1 is observed but brain size between
control and mutant groups was not affected (Figure 2.4c,d). Staining for cyclin B however
showed a slight accumulation in the cytoplasm of cells in both the optic lobes when compared to
wild-type controls (Figure2.4 c,d). Cyclin B is a substrate for the proteasome so this
accumulation suggests defective proteasome activity. Interestingly, degradation of cyclin B is
required for exit from mitosis (Castro et al., 2005). Likewise, dmPI31 mutant brains show altered
localization of the stem cell markers Deadpan and Prospero (Figure 2.4 e,f). In control lines, Pros
staining is restricted to the nucleus of GMCs and does not overlap with nuclear Dpn staining.
Dpn also shows restricted localization and typically marks mitotic areas of the optic lobes. In
mutants, Pros staining is diffuse, cytoplasmic, and overlaps with Dpn, whose expression pattern
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is greatly expanded. (Figure 2.4 e,f). Pros is a transcriptional repressor that is restricted to the
nucleus to downregulate cell cycle genes and restrict GMCs to one terminal mitosis. Dpn on the
other hand plays an important role in neuroblast self-renewal and specification. Reports have
shown that ectopic expression of Dpn promotes ectopic self-renewing divisions of neuroblast
(Zhu et al., 2012). Thus, it appears that dmPI31 plays a role in cell cycle exit and loss of this
protein results in cell cycle defects, accumulation of Dpn, and over-proliferation of neuronal
stem cells.
In order to determine the consequences of loss of PI31 through all stages of development, I
took advantage of the FLP/FRT technique that is used to generate mitotic clones in a
heterozygous animal in specific tissues and stages (Golic et al., 1997). The FLP/FRT technique
can yield mosaic wild-type, heterozygous, and homozygous mutant cells in a specific tissue of an
animal heterozygous for a wild-type and mutant allele. Using a heat shock inducible flippase, I
generated dmPI31 mutant clones by subjecting heterozygous larvae to 3 rounds of 1hr heat shock
over 72 hours. Similar to results obtained with antibody staining in dmPI31 mutant larva, larval
mutant clones did not show aggressive accumulation of poly-ubiquitinated proteins in the brain
or eye discs (Figure 2.5a). However, leg discs with patches of mutant clones showed marked
accumulation of poly-ubiquitinated proteins (Figure 2.5a,b). This may point to a more essential
role for PI31 in this tissue or a compensatory mechanism held by the brain and eye discs to
overcome proteotoxic stress. Of note, is the finding that DmPI31 was shown to be essential for
leg development, thus the effect of loss of PI31 in this compartment may be more detrimental to
proteasome function (Grubbs et al., 2013).
Additionally, I assayed PI31 function in adult tissues by generating mutant clones in the
adult photoreceptors using an eye specific flippase. I found that photoreceptors which lack
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dmPI31 rapidly degenerate and accumulate poly-ubiquitinated proteins, suggesting a defect in
proteasome function (Figure 2.6c). However, heterozygous photoreceptor axons also appear
affected with many displaying twisted and degenerative phenotypes as shown by GFP expression
in these axons (Figure 2.6c). Photoreceptor clones induced by eye specific flippase in a different
context also showed rapid degeneration. Live images of photoreceptors clones were taken with
the cornea neutralization technique using transgenes that express GFP specifically in
photoreceptors 1-6. Generation of mutant clones for Nmnat1, an essential enzyme in the NAD+
salvage pathway, does not show degeneration at 1 day PE and mutant cells can be seen by lack
of Tomato (red) but maintenance of GFP (green) (Figure 2.6a). These mutant cells are reported
to degenerate with age. However, dmPI31 mutant clones showed rapid degeneration of
rhabodmeres as early as 1 day PE (Figure 2.6b) suggesting an essential role for PI31 in
maintaining cellular health in this context.

38

Figure 2.4 dmPI31 mutants display elevated cyclin B and DCP-1
(a) 3rd instar larva of heterozygous dmPI31 mutants were used as a control to show the OL and
CB stained for anti-DCP-1 (an effector caspase, red), FK2 (green), and DAPI (blue). (a’) antiFK2, a marker for conjugated ubiquitin, stains large cells which are likely, neural progenitors. (b)
dmPI31 null mutant OL and CB stained for DCP-1 (red), FK2 (green), and DAPI (blue). (b’)
anti-FK2 staining shows cytoplasmic staining of large neural progenitors but no difference in
signal accumulation when compared to heterozygous larva. (c) Oregon-R strains were used as a
control for anti-cyclin B, anti-DCP-1, and anti-Dpn staining. Compared to the control strain,
dmPI31 mutants show accumulation of cyclin B and a slight accumulation of DCP-1 in a subset
of cells. Dpn expression, which typically marks mitotic areas of the optic lobe and is nuclear in
neuroblasts, is altered and appears in a large number of smaller cells, whose localization
coincides with neural progeny. (e) DmPI31 mutants show diffuse anti-pros (white) and anti-Dpn
(green) in the cytoplasm of cell clusters pointing to potential proliferation defects. Note that antiDpn again stains more cells and appears cytoplasmic in clusters of cells. (f) Control brains show
distinct anti-pros (white) staining that is high in neural progeny surrounding the neuroblasts,
which are marked by nuclear Dpn staining. All confocal images were taken at 63X
magnification.
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Figure 2.5 dmPI31 mutant clones show accumulation of ubiquitin in leg imaginal discs
DmPI31 mutant clones were generated using a heat shock promoter driven flippase to generate
clones in various tissues and assay accumulation of conjugated ubiquitin using anti-FK2. Larvae
were heat shocked for 1 hour in a 37°C incubator 3 times over 72 hours. (a) Confocal z-stack
images show anti-FK2 (green) accumulation in leg imaginal discs (LD) of 3rd instar larva. Wildtype clones are marked by RFP. Mutant clones in the eye disc (ED) and brain are outlined but
FK2 does not show significant accumulation in these tissues. Image is viewed at 20X
magnification. (b) Z-stack projections at 63X zoom show FK2 (green) accumulation in larval leg
disc clones mutant for PI31. Wildtype clones are labeled in red and do not show accumulation of
ubiquitinated proteins.
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Figure 2.6 dmPI31 mutants show various neuronal degeneration phenotypes
(a-b) Confocal images from the retina of living flies using the cornea neutralization technique.
Mosaic clones were generated by flippase-mediate recombination driven in the eye with ninaCGFP being expressed in the R1-R6 photoreceptors. (a) Mosaic clones of NMNAT, an essential
enzyme in the NAD+ salvage pathway, show the retention of photoreceptors (green) in 1 day old
flies. These photoreceptors are reported to degenerate with age. Tomato (red) marks wild-type
clones. (b) Mosaic clones of PI31-/- show that only wild type clones (red) retain photoreceptors
(green) while mutant photoreceptors rapidly degenerate and lack ninaC-GFP (green). (c) PI31
mutant mosaic clones were generated in the eye and whole mount staining of adult optic lobes
show the accumulation of conjugated ubiquitin (FK2) in mutant photoreceptor axons (lack of
GFP and marked with brackets) from R7 and R8 photoreceptors. These mutant axons also show
severe degeneration indicating an essential role for DmPI31.
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2.3.3 Neuron specific knockdown of dmPI31 results in eclosion and motor neuron defects
DmPI31 mutant larva are reported to develop melanotic tumors (Bader et al., 2011) but
also show impairments in crawling and response to mechanical touch. I sought to address
whether DmPI31 has additional neuronal functions outside of the brain. The larvae motor
neurons are a well-defined system and display stereotyped projections thus making altered
phenotypes identifiable through immunostaining. I assayed DmPI31 mutant larva for defective
motor neuron phenotypes. To do this, the motor neurons between muscle 6 and muscle 7 were
stained for HRP, labeling neuronal membranes, and Bruchpilot (Brp) that labels the presynaptic
active zones (AZs). DmPI31 mutant motor neurons show less AZs on average compared to
controls (w1118: 421.5 +/- 150 foci, dmPI31-/-: 271.9 +/- 84.4 foci, *p= 0.021) without any
significant differences in branching or bouton number (w1118: 58 +/- 21 boutons, dmPI31-/-: 45.3
+/- 22 boutons, p=0.053; w1118: 12.4 +/- 3.6 branches, dmPI31-/-: 13.1 +/- 4.7 branches, p=0.8)
(Figure2.7a-b). The reduction in AZs points to a role for dmPI31 in neurons and specifically at
the axon terminals. To address the specific effect of DmPI31 on the adult neurons, I used RNAi
against PI31 driven by a pan-neuronal driver nervana2 and found that homozygous flies fail to
eclose completely from the pupal casing. The head and thorax of these flies emerge but they
continue to struggle and never escape the casing while their heterozygous counterparts emerge
within seconds (data not shown). Since this phenotype is depicted, I considered the possibility
that the motor neurons were being affected in the hind legs (L3). To test these hypothesis, I
manually removed partially eclosed living flies from their pupal casing and dissected the L3 legs.
The femurs were stained with HRP which labels neurons and the amount of innervation was
assayed by counting branch length and number (Figure 2.7c-e). Interestingly, PI31 knockdown
resulted in shorter branched motor neurons with a tangled phenotype that did not extend the
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length of the femur as in control lines (Figure 2.7d). Overepxression of PI31 showed a similar
branch length and motor neuron morphology as the control (Figure 2.7e) and these results were
quantified and shown to be significant (Figure 2.7f). It is of note, that the cell bodies of these
motor neurons reside in the adult VNC located in the thorax and the staining here identifies the
axons that project into the L3 legs.
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Figure 2.7 Neuronal knockdown of DmPI31 results in eclosion and motor neuron defects
(a) Wandering 3rd instar larva neuromuscular junction (NMJ) from control flies and (a’) PI31
mutant larva were stained with anti-HRP (red) and anti-Brp (green) to mark the presynaptic
neuron and presynaptic active zones, respectively. Representative photos of the NMJs between
muscles 6 and 7 are shown and taken at 63x magnification. PI31 mutant larva display less active
zones while the bouton number and branch number do not significantly change. (b)
Quantification of active zone number (w1118: 421.5 +/- 150 foci, dmPI31-/-: 271.9 +/- 84.4 foci,
*p= 0.021), bouton number (w1118: 58 +/- 21 boutons, dmPI31-/-: 45.3 +/- 22 boutons, p=0.053),
and branch number (w1118: 12.4 +/- 3.6 branches, dmPI31-/-: 13.1 +/- 4.7 branches, p=0.8). n=9
(c-e) Whole mount dissection of adult L3 leg were stained with anti-HRP to mark neurons. (c)
Control L3 legs show neurons that are elongated and branched. Purple overlap shows a set of
traces that were used for analysis in ImageJ which indicate the average branch length as 143.1
pixels. (d) RNAi mediated knockdown of PI31 results in shorter and twisted neurons with an
average length of 100.9 pixels. These neurons also appear to show less elongated branch
numbers. (e) PI31 overexpression in neurons shows elongated neurons similar to the control with
an average length of 136.61 pixels.(f) Quantification of branch length for n=3 for adult L3 legs
shows that RNAi of PI31 significantly reduced branch length.
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2.3.4 DmPI31 levels alter lifespan in Drosophila melanogaster
Drosophila have been a useful model to study the effect of proteins on aging and healthspan due to their relatively short lifespan. Reports have shown that proteasome activity decreases
with age and results from a decrease in proteasome assembly (Tonoki et al., 2009). TNKS, an
ADP-ribosyltransferase, was identified as a direct binding partner that modulates PI31 activity
through ADP-ribosylation. ADP-ribosylation of PI31 by TNKS is shown increase 26S
proteasome assembly by reducing the affinity of PI31 to the alpha subunits of the 20S
proteasome to relieve 20S inhibition (Cho-Park and Steller, 2013). DmPI31 provides a link
between proteasome assembly and aging. Thus, I sought to address whether activating PI31 later
in life could maintain the activity of proteasome and thus extend lifespan in Drosophila. To do
this, I used a temperature sensitive Gal4 driver under the alpha tubulin promoter (Tubulin-Gal4,
tubulin-Gal80ts) to drive expression of various UAS transgenes. Tubulin-Gal80ts inhibits the
expression of Gal4 until flies are moved to the restrictive temperature, 30°C. Using these lines, I
was able to turn on and off gene expression in a temporal fashion and determine whether
overexpression of dmPI31 late in life can extend lifespan. Age matched embryos were collected
and distributed into bottles, so as to prevent overcrowding. Early eclosers were discarded, and
age matched flies were collected and allowed to sexually mature for 3 days before male and
females were separated into respective vials containing 30 flies each. Lines were allowed to
develop at room temperature and flipped every 3 days until switched to higher temperatures of
25°C at day 25. At this temperature, it is excepted that Gal80ts is partially degraded but still
restricts some transgene expression. This was done since, dmPI31 overexpression is shown to be
lethal at high levels. In both males and females expression of RNAi against PI31 decreases
average lifespan (RNAi PI31 in males 33 +/- 1.74 days, RNAi PI31 females 27 +/- 1.41 days)
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compared to control (male 38 +/- 0.69 days, female 36 +/- 0.60 days) (Figure 2.8a,b).
Interestingly, males but not females display lifespan extension when overexpressing dmPI31
(UAS dmPI31 males 46 +/- 0.91 days, UAS dmPI31 females 34.14 +/- 0.83 days) (Figure
2.8a,b). In a more stringent assay, age matched female flies were developed and aged at 18°C
until being switched at day 47 to either 25°C or 29°C. At 25°C , the lifespan of female flies
overexpressing dmPI31 does not significantly increase compared to control lines however, at
29°C both females showed increased lifespan under PI31 overexpression compared to control
(Figure 2.8c). This experiment points to levels of dmPI31 being important for lifespan extension
since higher temperatures result in greater induction of the transgenes. The differences seen
between male and female flies could be due to expression differences between the sexes as it is
known that dmPI31 is highly expressed in the testes.
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Figure 2.8 DmPI31 levels influence lifespan in Drosophila
Lifespan assays were conducted with transgenic flies expressing various PI31 constructs under a
temperature sensitive tubulin Gal4 promoter. OASIS 2 online application was used for survival
analysis and to conduct statistical analysis on the lifespan of PI31 knockdown and
overexpression flies compared to controls. (a-b) Flies were aged matched at RT, and females (a)
and males (b) were reared separately at RT after reaching sexual maturity. At day 25 flies were
switched to 25°C to drive expression of transgenes. (a) In female flies, knockdown of PI31
resulted in shortened average lifespan (27 days) compared to control (36 days), *p=3.6 x 10-4.
Overexpression of PI31 did not significantly alter lifespan (34 days) compared to control,
p=3.84. (b) Male flies also show reduced lifespan when PI31 is knocked down (33 days)
compared to control (38 days), *p=0.0025. In males however, overexpression of PI31 extend
lifespan (46 days) compared to control (38 days), *p=2.8 x 10-9. (c) Female flies were subject to
more stringent induction of PI31 transgene expression with temperature sensitive lines developed
and reared at 18°C and then switched to 25°C or 29°C at 47 days PE. At 25°C, average lifespan
between control (73 days) and PI31 overexpression lines (78 days) is extended by 5 days. With
higher transgene expression at 29°C, PI31 overexpression results in an 18 day increase in
lifespan compared to control (57 days).
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2.4 Discussion
The essential role of DmPI31 in the Drosophila nervous system was highlighted in this
chapter through studies on localization and mutant phenotypes. It was shown that DmPI31
expression appears ubiquitous but is most abundant in the larval and adult central brain. In
addition, DmPI31 expresses in the photoreceptor axons of the adult optic lobes meaning there is
a possible mechanism that transports DmPI31 to these distal locations. Within the central brain
in larvae, DmPI31 expresses highly in the neuroblasts, which are the neuronal stem cells that
self-renew and asymmetrically divide to produce the diversity of neurons in the Drosophila
brain. Here in the neuroblasts, DmPI31 is shown to co-express with the proteasome subunits a2
and Rpt3. It is likely that neuroblasts require higher levels of proteasomes to keep up with the
demands of proliferation and these proteasomes require a stringent level of regulation. In line
with this is the observation that dmPI31 mutants accumulate cyclin B and show expanded
numbers of Dpn positive cells. Cyclin B is typically degraded by the 26S proteasome to initiate
the termination of mitosis (Tokumoto et al., 1997). The accumulation of cyclin B indicates
impaired 26S proteasome activity in dmPI31 mutants leads to aberrant mitosis. Since the size of
the brain does not appear to change, it would be interesting to check the balance between
apoptosis and proliferation with TUNEL staining and EdU (5-ethynyl-2’-deoxyuridine)
incorporation respectively. It is possible that DmPI31 in brain tissue is regulated in a different
manner than in the leg discs, since polyubiquitinated proteins do not accumulate to the same
extent. The decreased number of active zones in the larval NMJ and decreased branch number in
the adult motor neurons points to dmPI31 playing a role in synaptic remodeling as well. Whether
this is through proteasome mediated degradation of specific substrates is yet to be determined but
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a screen for modifiers of the photoreceptor degeneration seen using the cornea neutralization
technique in dmPI31 clones could lead to potential candidates.
This chapter emphasis that proteasome activity needs to be temporal and spatially
restricted to prevent nonselective protein degradation. The subcellular localization of dmPI31
and mutant phenotypes link this proteasome interacting protein to essential functions in neuronal
maintenance and health. Lifespan assays show that reduced levels of PI31 lead to shorten
lifespan while overexpression can extend lifespan in males, and at very high levels in females.
However, whether alterations in DmPI31 levels causes differential proteasome assembly during
lifespan extension phenotypes is not yet known.

2.5 Materials and Methods

Fly stocks and culturing
All stocks were maintained on a standard cornmeal-molasses medium containing 3% yeast at
25°C unless otherwise indicated. John Belote generously provided the alpha2-GFP and Rpt3GFP lines while PI31 mutants and tagged lines were generated previous in the lab by Maya
Bader. RNAi for PI31 (105476) was obtained from VDRC. Rh1-GAL4,ey-FLP; UAS-GFPninaC; FRT82BninaE-dTomato-ninaC and Rh1-GAL4,ey-FLP; FRT42DninaE-dTomato-ninaC;
UAS-GFP-ninaC were generated by former lab members Alexis Gambis and Bertrand
Mollereau. Oregon-R or w1118 were used as control lines. Nervana2Gal4 (6794), was obtained
from Bloomington.
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Brain dissection and immunostaining
3rd instar larva imaginal discs or adult brains were dissected in ice cold PBST (0.1% Triton-X)
and fixed in 4% paraformaldehyde (PFA) for 40min on ice. After fixation, CB and VNC were
separated from other discs and washed 3X in cold PBST before incubation for 1 hour in 2% BSA
blocking buffer. Primary antibodies were diluted in 2% blocking buffer plus 5% normal donkey
serum and incubated overnight at 4°C. anti-Deadpan (1:100, 11D1BC7 abcam195173), antiProspero (1:100, MR1A), anti-cyclin-B(1:100, F2F4) were all obtained from DSHB while mouse
monoclonal anti-FK2 (1:100, Stressgen), cleaved anti-DCP-1 (1:200, cell signaling technologies)
were obtained from the respective companies. Secondary antibodies corresponding hosts were
diluted (1:500) in blocking buffer and incubated overnight at 4°C before samples were washed
3X in PBST. Brains were mounted in Vectashield plus DAPI and imaged with Zeiss confocal
microscope by taking z-stacks and making maximum intensity projections.

Generation of mitotic clones
Lines of yw hsflp; FRT42DubiRFPn/s were crossed to FRT42D PI31HR11 and heat shocked at
37°C 24 hours after egg laying and every 24 hours for 3 days before 3rd instar larva were
dissected for imaginal discs and fixed in 4% paraformaldehyde. Tissues were washed 3X with
PBST and blocked in 2% BSA. For poly-ubiquitin staining, mouse monoclonal FK2 was used
(1:100) and incubated overnight at 4°C. Primary antibody was washed 3X for 10min each at
room temperature before addition of secondary Donkey anti-mouse-FITC (1:500) which was
incubated overnight at 4°C. Tissues were washed 3X with PBST and mounted in Vectashield
plus DAPI. Confocal z-stacks were taken of mitotic clones marked by the absence of RFP and
subsets of images were taken before applying maximum intensity projections using ImageJ.
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Motor neuron whole-mount immunostaining
3rd instar larva of either control or PI31 mutants lines were dissected and immunostaining of
NMJs were carried out according to the following protocols (Brent et al., 2009a, 2009b). Briefly,
larval were filleted open using minutien pins and organs were carefully removed. Body walls
were fixed with 4% PFA in HL3 saline (NaCl 70mM, KCl 5mM, CaCl2 1.5mM, MgCl2 20mM,
NaHCO3 10mM, sucrose 115mM, and Hepes 5mM) for 25min and then washed 3X with HL3
saline. After fixation samples were moved to 1.5mL Eppendorf tubes containing 2% BSA
blocking buffer and blocked for 30min at RT. Then primary antibody a-Brp (1:500, nc82) and
Cy3 Goat-Horseradish peroxidase (1:500, Jackson immunoresearch) were added and incubated
overnight at 4°C. Subsequently, gentle washing with PBST 3X was done before adding
secondary antibody Donkey anti-mouse FITC (1:500) overnight in cold room. Samples were
washed and NMJs between muscle 6/7 were imaged with z-stacks at 63X magnification with
Zeiss Confocal microscope.

Live imaging of Drosophila photoreceptors
Generation of mosaic adult Drosophila photoreceptor clones was done following the protocol
described in (Dourlen et al., 2013). Briefly, Rh1-GAL4, ey-FLP; UAS-GFP-ninaC; FRT82B
ninaE-dTomato-ninaC and Rh1-GAL4,ey-FLP; FRT42DninaE-dTomato-ninaC; UAS-GFPninaC were crossed to FRT82BNmnat1 (BL 24886) and FRT42D PI31HR11 respectively. Adult
flies of the correct genotype were anesthetized and mounted in low melt agarose at 45-55°C by
submerging one wing of the fly into the agarose along with half of the head to prevent movement
during imaging. Clones were identified by confocal imaging using a 40X water objective.
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Drosophila lifespan assays and OASIS analysis
Lifespan analysis was carried out on UAS lines crossed to the Tubulin Gal4, Tubulin Gal80
temperature sensitive driver at indicated temperature either 18, 25, or 29°C. Stock of these lines
were made over balancers and isogenized by backcrossing to w1118 lines. The following
protocols were followed for lifespan assay set up and data analysis (Han et al., 2016; Linford et
al., 2013). Lines were expanded and age matched eggs were collected and put into bottles. Aged
matched eggs were allowed to reach sexual maturity and male and females were separated 30 to
each vial. Vials were flipped every 3 to 4 days and the number of dead flies in each vial were
scored. Statistical analysis was carried out using OASIS 2 online software.
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3. Metabolic influence on proteasome regulation by NAD+

3.1 Summary
An understanding of how 26S proteasomes are regulated in response to metabolic changes within
the cell is lacking but are critical to understanding why this system begins to fail in aging and
age-associated diseases. DmPI31 provides a potential target for metabolically regulated
proteasome modulation because of its modification by TNKS-mediated ADP-ribosylation. In this
chapter, I explore proteasome regulation during two metabolic states, dietary restriction (DR) by
means of yeast dilution and NAD+ repletion through nicotinamide and nicotinic acid
supplementation. Drosophila at various developmental time points were subject to diets with
defined amounts of yeast or the NAD+ precursors, nicotinamide (Nam) and nicotinic acid (Na).
Both DR and supplementation of NAD+ precursors are shown to boost proteasome activity. I
show that DmPI31 is necessary for the increase in proteasome activity seen during NAD+
repletion and more specifically the activity of 26S proteasomes. The rise in proteasome activity
coincides with an enhanced expression of DmPI31 and increased 26S proteasome assembly.
These findings demonstrate that proteasomes are actively regulated during varied metabolic
states and demonstrate a potential pathway by which proteasomes can quickly adapt to metabolic
changes. I conclude the chapter with studies in the context of Nmnat, an essential enzyme
involved in the synthesis of NAD+ from Na and Nam. Generation of nmnat-/- photoreceptor
clones reveals a decrease of DmPI31 along with photoreceptor axon degeneration. However,
DmPI31 appears not to physically interact with Nmnat. Instead, feeding the flies NAD+
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precursors in an nmnat-/- background can rescue the loss of DmPI31 providing further evidence
that DmPI31 and proteasomes are regulated by NAD+ metabolism.

3.2 Rationale
The degradation or cleavage of substrates by the UPS is essential for many cellular
processes including apoptosis, cell cycle control, cell signaling, and protein quality control. The
structure and function of proteasomes is well known but how they are regulated in vivo is not
well understood, most likely due to tissue and context specific regulators. However, evidence
that proteasomes are actively regulated during metabolic changes exists with examples of
posttranslational modifications of proteasome subunits, the accumulation of metabolic
abnormalities during proteasome inhibition, and a decline in proteasome function during aging
(Zhang et al., 2003, 2007b, 2007a; Tomaru et al., 2012; Tonoki et al., 2009). A potential
candidate to explore in this context is the proteasome regulator, DmPI31, which was found to be
an activator of 26S proteasomes in vivo by increasing assembly. This increase in assembly comes
about through the posttranslational ADP-ribosylation of DmPI31 by the ADP-ribosyltransferase,
tankyrase (TNKS) (Cho-Park and Steller, 2013). The source of ADP-ribose units is nicotinamide
adenine dinucleotide (NAD+), which has been shown in a variety of systems to be
neuroprotective and increase healthspan (Lehmann et al., 2016; Ocampo et al., 2013; Verdin,
2015; Wang et al., 2008; Zhang et al., 2016). Thus, NAD+ provides a link between cellular
metabolism and proteasome activity. In our natural diet, nicotinic acid, nicotinamide, and
tryptophan can be used to synthesize, NAD+, which is a key substrate for NAD+ consuming
enzymes and a co-enzyme for redox reactions where in its reduced state becomes NADH.
Increasing intracellular NAD+ content is involved in maintaining neural integrity in a variety of
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contexts (Lehmann et al., 2016; Ocampo et al., 2013; Verdin, 2015) and is capable of extending
healthspan (Anderson et al., 2003; Yoshino et al., 2011; Zhang et al., 2016). Whether these
effects are mediated by gene expression changes, improved mitochondrial health, or increased
autophagy have been explored but do not provide a definitive picture. Thus, I sought to explore
the role of NAD+ repletion on proteasome activity by supplementing the diets of Drosophila
with the NAD+ precursors nicotinamide (Nam) and nicotinic acid (Na), at times collectively
referred to as niacin. Dietary restriction is also explored since it is shown to increase NAD+
levels and is the only non-genetic manipulation to reproducibly increase healthspan across
species.
Here, I describe a link between cellular metabolism and proteasome activity. Through dietary
supplementation, I show that both nicotinamide and nicotinic acid can increase proteasome
activity, proteasome assembly, and protein levels of DmPI31. These findings are corroborated by
knockdown of Nmnat, a key enzyme in the synthesis of NAD+ metabolism, which also shows
reduced proteasome activity and DmPI31 expression. These two proteins however are not shown
to physically interact. Instead, I speculate that the loss of the neuroprotective, Nmnat, results in a
signaling pathway that lowers the expression of dmPI31 to restrict proteasome activity in
degenerating neurons.

3.3 Results
3.3.1 Nicotinamide and nicotinic acid increase proteasome activity and levels of DmPI31
NAD+ provides a potential link between cellular metabolism and proteasome activity. Both
dietary restriction and NAD+ repletion via nicotinamide and nicotinic acid have been shown to
be beneficial for extending lifespan and healthspan across species but few studies have shown
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how these interventions might impact proteasome regulation. To test whether boosting NAD+
levels could improve proteasome activity, I age-matched Drosophila embryos and distributed
them on diets supplemented with nicotinamide (Nam) or nicotinic Acid (Na) as indicated in
Figure 3.1a. Both metabolites are NAD+ precursors in the NAD+ salvage pathway (Figure 1.3).
A cornmeal-molasses based food recipe was developed and supplemented with varied
concentrations of Nam or Na (Figure 3.1b). Wild-type Oregon-R strains were fed on either Nam
or Na supplemented food and whole-body lysates were assayed for cleavage of the luminogenic
peptide Suc-LLVY-aminoluciferin indicative of the chymotrypsin-like activity of the
proteasome. MG132, a potent proteasome inhibitor, is used as a negative control to determine
specificity of substrate cleavage for the proteasome. When flies are fed with 10mM Na,
proteasome activity increases 23% compared to non-supplemented control (Figure 3.2a). Feeding
with 10mM Nam does not cause a significant increase in activity however increasing the amount
of Nam to 30mM increases proteasome activity by 25%. High levels of Na increase proteasome
activity by 18% in this assay which is still significant but high levels of Na consistently show
less activity which may indicate slight toxicity. All values were normalized as a percentage of
non-supplemented controls (MG132: 38.06 +/- 7.69 RLU, ***p=1.7x10-6; Na 10mM:123.06 +/8.71 RLU, **p=0.003; Nam 10mM: 102.39 +/- 11.02 RLU, p=0.39; Na 30mM: 118.07 +/- 10.08
RLU, *p=0.049; Nam 30mM: 125.65 +/- 10.09 RLU, *p=0.013) (Figure 3.2a). To further
investigate the impact these metabolites have on proteasome activity, western analysis was
carried out on head lysates from control, w1118, flies fed on varied concentrations of Nam and Na.
Endogenous levels of DmPI31 were assayed and interestingly DmPI31 protein expression is
increased with each concentration of either Nam or Na. Strikingly a two-fold increase was
observed with supplementation of Na 10mM (Figure 3.2b). The 20S proteasome subunit, a7,
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was also assayed and showed a slight decrease in subunit expression except in the case of Nam
20mM. Interestingly in dmPI31 mutants, where the whole larval lysate was taken, a7 expression
is increased compared to tubulin. This is potentially due to an adaptive feedback loop caused by
loss of DmPI31 or possibly differential a7 levels across tissues. Whole body lysates from males
fed on control or 10mM Na again show a significant increase in DmPI31 expression indicating
that NAD+ repletion may regulate DmPI31 in a range of tissues. Many of the experiments to
follow will use a UAS driven HA tagged DmPI31, thus I also tested whether NAD+
supplementation could increase DmPI31 in this context. Using GMR-Gal4 to drive expression of
HA-PI31 in the eye, head lysates from flies fed a Na dilution series were taken and resolved on
SDS-PAGE gel to assay for changes in dmPI31 levels. Again, Na increases dmPI31 levels but
high levels of Na typically show diminished expression most likely due to toxicity (Figure 3.2c).
However, the increase in DmPI31 seen at Na 40mM could be due to many factors including
reduced consumption of food by the flies, compensatory gene regulation caused by decreased
DmPI31, or quenching of an intermediary that typically inhibitions DmPI31 expression.
In order to better understand the effect of dietary supplementation in vivo, I took advantage
of the hs-EGFP-Nintra in vivo proteasome sensor. This transgenic line expresses a Notch
intracellular domain (Nintra) with a PEST degradation signal, that is a known target of the UPS,
fused to EGFP downstream of the heat-shock promoter. Upon heat shock, EGFP-Nintra signal
accumulates and at 1 hour reaches peak levels. If proteasomes are functional the signal degrades
and is only slightly detectable after 4 hours. To test whether Nam or Na could increase in vivo
proteasome activity, flies expressing a dominant temperature sensitive proteasome mutation in
the b2 subunit (DTS7) were cross to the sensor to give a baseline level of proteasome
impairment. Upon heath shock these transgenic flies show stabilization of EGFP-Nintra at 1 hour
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post eclosion. In parallel flies fed on 30mM nicotinamide were heat shocked and showed less
accumulation of stable EGFP-Nintra signal (Figure 3.2d). This points to a means by which Nam
either primes proteasomes prior to heat shock or increases the rate at which proteasome assembly
and subsequent activity occurs. Either way it is important to consider whether to this is due to
transcriptional or post-transcriptional changes that occurring during Nam feeding. Since ADPribosylation of dmPI31 is shown to increase 26S proteasome activity, I sought to investigate
whether dmPI31 is necessary for the increased proteasome activity seen under Na and Nam. I
tested whether increased proteasome activity is still observed in transgenic flies expressing RNAi
against dmPI31 and flies expressing HbYX deleted dmPI31 upon feeding with 10mM Na.
Proteasome activity was measured in lysates using the in vitro method and in both cases feeding
did not significantly alter proteasome activity (Figure 3.2e). On the other hand, control lines fed
10mM Na and overexpression of full-length PI31 increased proteasome activity by about 40%
compared to control. This suggests that dmPI31 is required for the increase in proteasome
activity upon Na and Nam feeding. Consistent with previous findings, the HbYX motif is
required for full proteasome activity promoted by full length dmPI31 but the PI31DHbYX still
confers a modest increase compared to control, which becomes significant upon 10mM Na
(Compared to Tubulin, MG132: 20.42 +/- 6.15 RLU, ***p=3.03x10-5; Na 10mM: 142.12 +/11.85 RLU, *p=0.012; UAS-PI31: 133.37 +/- 10.48 RLU, *p=0.027; RNAi PI31 108.67 +/- 6.34
RLU, p=0.281; RNAi PI31 + Na 10mM: 122.11 +/- 24.693 RLU, p=0.422; PI31DHbyX:
119.967 +/- 12.281 RLU, p= 0.208; PI31DHbYX + Na 10mM : 130.739 +/- 9.033 RLU,
*p=0.017). This is interesting because the HbYX motif was found to be necessary for TNKS
binding to dmPI31, meaning that a potential TNKS independent pathway exists that increases
proteasome activity upon NAD+ repletion. However, one caveat of the in vitro proteasome assay
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is that it does not differentiate between 20S and 26S proteasome activity. Thus, average
proteasome activity upon different feeding conditions may not be reflective of shifts that occur in
20S versus 26S activity.

Figure 3.1 Experimental design for nutrient supplementation
(a) Schematic of the experimental set up used to supplement different concentrations of NAD+
precursors. Flies were allowed to lay eggs on apple juice plates + yeast paste at RT for 22 hours.
These eggs were discarded and fresh plates were used to collect age matched eggs for 20 hours.
These eggs were harvest and divided onto standard cornmeal molasses medium supplemented
with varying concentrations of NAD+ precursors, nicotinic acid and nicotinamide. After eclosion
flies were allowed to reach sexual maturity and then transferred to fresh medium before being
subjected to experimental assays. (b) Chart listing the concentrations of key components in the
food. Note that 3% yeast was used as the standard concentration.
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Figure 3.2 Nicotinamide and nicotinic acid increase proteasome activity and dmPI31
(a) Average luminescence produced by cleavage of peptide recognized by chymotrypsin-like
activity of the proteasome. Values were normalized to the control in each experiment and
MG132, a proteasome inhibitor was used as a control for proteasome specific activity. Na
10mM, Na 30mM, and Nam 30mM increase proteasome activity compared to the control, n=7.
(b) Western analysis on wildtype lysates from adult flies subject to NAD+ supplemented diets.
Quantification of DmPI31 normalized to tubulin shows an increase in PI31 with Nam 10mM,
Nam 30mM and Na 10mM supplementation. Na 30mM did not show a significant increase in
DmPI31 (c) Western blots from wild type male whole body lysates of flies show an increase in
DmPI31 levels after supplementation of Na 10mM for 6 days PE compared to control. To
address the effect of Na on DmPI31 levels more clearly a dilution series was conducted with
transgenic lines expressing PI31 under the UAS promoter driven by GMR-Gal4 in the eye. Head
lysates were taken and show that DmPI31 levels increase in a dose dependent manner until Na
20mM at then increase again at Na 40mM. Supplementation of NAD+ alone did not increase
proteasome activity when added directly to lysates and does not show increases in PI31 protein
level. (d) Transgenic flies expressing a truncated Notch ligand, Nintra-GFP, crossed to flies
expressing mutant proteasome subunit, DTS7, under GMR-Gal4 promoter. 3rd instar larvae fed
control or 30mM Nam were heat shocked for 30min at 37°C and allow to recover for 1 hour.
Control fed larva show accumulation of GFP in eye discs but Nam fed flies show rapid
degradation of GFP. e) Proteasome activity did not increase between control and Na 10mM fed
fly lysates from a PI31 RNAi or PI31DHbYX background. On the other hand, control lines fed
10mM Na and overexpression of full-length PI31 increased proteasome activity by about 40%
compared to control. Statistical analysis was carried out using a two-tailed, paired, t test
(Compared to Tubulin, MG132: 20.42 +/- 6.15 RLU, ***p=3.03x10-5; Na 10mM: 142.12 +/11.85 RLU, *p=0.012; UAS-PI31: 133.37 +/- 10.48 RLU, *p=0.027; RNAi PI31 108.67 +/- 6.34
RLU, p=0.281; RNAi PI31 + Na 10mM: 122.11 +/- 24.693 RLU, p=0.422; PI31DHbyX:
119.967 +/- 12.281 RLU, p= 0.208; PI31DHbYX + Na 10mM : 130.739 +/- 9.033 RLU,
*p=0.017).
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3.3.2 Proteasome activity and DmPI31 levels increase with dietary restriction
Dietary restriction is thus far the only non-genetic application that has been reported to
extend lifespan across several species. Dietary restriction (DR) is shown to ameliorate agerelated proteasome decline in some tissues (Dasuri et al., 2009; Li et al., 2008; Zhang et al.,
2007c) as well as increase NAD+ levels (Banerjee et al., 2012)(Lin et al., 2000). However, the
mechanism by which proteasome activity is altered under DR is yet to be determined. Since, DR
increases NAD+, I first sought to determine whether DR can also induce an increase in dmPI31
levels. In this case, DR is defined as yeast restriction from 3% to 0.25% while the composition of
molasses is unchanged. Drosophila whole body male or head lysates expressing mcherrydmPI31 under the PI31 endogenous promoter were fed control or DR food as embryos and
resolved on SDS-page gel and immunoblotted for dmPI31. Head lysates showed a modest
increase in dmPI31 expression while whole body lysates showed no change when normalized to
controls (Figure 3.3d). Interestingly, the increase in dmPI31 is associated with a reduced
expression of a7 which also occurs in whole body DR fed flies (Figure 3.3d). It is noteworthy to
add that DR restricted flies are comparably smaller than their control fed counterparts. This may
point to developmental transcriptional changes that occur during DR that alter the expression of
core proteasome subunits. Head lysates do not distinguish between dmPI31 in the brain, eye, or
muscle cells. To differentiate between the tissues in the head, larva brains expressing mCherrydmPI31 under the PI31 endogenous promoter were fed on control or DR food. Confocal z-stack
projections show increased mCherry-dmPI31 under DR than under control fed lines. The
localization of PI31 does not appear altered and still co-localizes with cells expressing deadpan
(Dpn), the neuroblast marker (Figure 3.3a-c). Wild-type fly lysates subject to DR food were
assayed for proteasome activity using the in vitro assay and showed increased proteasome
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activity in both head and whole-body fractions however only the whole-body lysates showed a
significant increase in activity (compared to Control whole body: 4202.61 +/- 44.12 RLU,
MG132:4202.61+/- 44.12 RLU, **p=0.007; DR whole body: 5032.53 +/- 48.54 RLU,
**p=0.002; Control heads: 2294.74 +/- 152.23 RLU; DR heads: 2505.34 +/- 52.95 RLU, p=0.21)
(Figure 3.3e). Given, this result it may be that the ratio between a7 and dmPI31 is important for
increased proteasome activity during DR or that the short term effected of DR is more
pronounced in tissues outside the head, like muscle or intestine. These results show that
proteasome activity is regulated under DR and the dmPI31 pathway may participate to regulate
proteasomes under these conditions in the brain.
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Figure 3.3 DR increases dmPI31 expression and proteasome activity
Confocal z-projections of larval brains showing an increase in PI31::mcherry-PI31 upon dietary
restriction by means of yeast restriction. (a) Control 3rd instar larval brains showing mcherry
background fluorescence (red) and counter stained with anti-Dpn (green) to mark neuroblasts
within the CB, OLs. The merged image shows DAPI staining of all nuclei. (b) Control fed 3rd
instar larval brains expressing mcherry-PI31 under the PI31 endogenous promoter. Z-projections
show PI31 expression in the CB and VNC that co-expresses with anti-Dpn (green) staining. (c)
3rd instar larva fed on a DR diet show increased mcherry-PI31 expression compared to control
fed larva with anti-Dpn (green) again staining neuroblasts. (d) Western blot analysis from adult
fed flies shows DmPI31 protein levels increase upon rearing on DR food compared to control in
head lysates but not in whole body. The 20S proteasome subunit, alpha7, show decreased
expression on DR diet compared to control in both head and wholebody lysates. (e) Lysates from
adult flies on DR diets showed an increase in proteasome activity. Total protein from either
whole body males or heads only were extracted and proteasome activity was measured using the
fluorogenic-peptide hydrolysis at 10min. Values were normalized to amount of tubulin
determined by western analysis and plotted as relative luminescence unites (RLU). MG132 was
used as a control for specificity of proteasome activity. Error bars are the result of 3 intendent
assays. Statistical analysis was carried out using a two-tailed, paired, t test, (compared to Control
whole body: 4202.61 +/- 44.12 RLU, MG132:4202.61+/- 44.12 RLU, **p=0.007; DR whole
body: 5032.53 +/- 48.54 RLU, **p=0.002; Control heads: 2294.74 +/- 152.23 RLU; DR heads:
2505.34 +/- 52.95 RLU, p=0.21).
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3.3.3 NAD+ repletion increases proteasome assembly
Given that proteasome activity is shown to increase under Na, Nam, and DR conditions and
the limitation of the in vitro assay to distinguish between 20S and 26S activity, I examined
whether subsequent changes in proteasome assembly are a contributing factor. Proteasome
complexes from wildtype flies that were fed either Nam or Na, were separated in their native
conformation using gel electrophoresis and blotted for the proteasome subunit, a7 which
incorporates into 20S and 26S proteasomes. Total protein concentration was measured using the
BCA assay, normalized, and equal amounts of protein were loaded for each condition. To
determine whether Na and Nam supplementation could increase proteasome activity specifically
in the brain, head lysates were collected from wildtype fed flies and subjected to native analysis.
Blotting the membrane after transfer with the 20S subunit a7 showed that feeding with Nam or
Na increased overall 26S assembly but Nam at 20mM and Na at 10mM showed the greatest
increase in 26S proteasome assembly compared to controls (Figure 3.4a). As an internal control,
26S proteasome complexes were normalized to the amount of 20S and in this case Na 10mM
showed the greatest increase in 26S/20S ratio. This condition however also resulted in a loss of
20S amounts which may be due to toxicity (Figure 3.4a’). Considering that NAD+ is also a
major redox substrate, Na may initially cause an imbalance in the NADH/NAD+ ratio tipping the
scales toward oxidative stress, which has been shown to cause proteasome disassembly (LivnatLevanon et al., 2014). To test whether these proteasomes have increased catalytic activity, I
performed an in-gel proteasome peptidase assay where cleavage of suc-LLVY-AMC results in
fluorescence that can resolve the activity contributed to different proteasome species. I show that
feeding with 20mM Nam and 10mM Na increases 26S activity consistent with increased
assembly (Figure 3.4a). 20S proteasome activity in-gel can also be assayed with the addition of
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0.02% SDS, which opens the “gate” of the core particle to allow entry of substrates. Nam 20 and
Na 10 again show the greatest increase in 20S activity compared to control (Figure 3.4a).
One possible mechanism by which Nam and Na supplementation increases proteasome
activity is through TNKS mediated ADP-ribosylation of PI31. Increasing NAD+ increases
substrate availability for TNKS, which may lead to increased ADP-ribosylation of PI31 and an
increase in proteasome assembly. Since, dmPI31 mutants live to the larval stage, I tested whether
feeding mutant larval could increase proteasome assembly. Interestingly, dmPI31 mutants show
less double capped 26S proteasomes and also show a smaller intermediary form that still
maintains catalytic activity (Figure 3.4b) but feeding does not change the levels of 26S
proteasome complexes. 20S proteasome amounts are also not significantly different between
control and Nam fed lines (Figure 3.4b’) but the 20S proteasomes under control fed larval show
reduced 20S activity but upon feeding 20S activity is restored. This could point to dmPI31
having a role in maintaining 20S proteasome stability and upon feeding NAD+ precursors could
confer enhanced stability. It is reported that NADH, the reduced form of NAD+, can stabilize
proteasomes independent of ATP (Tsvetkov et al., 2014) thus supplementation with precursors
could also lead to enhanced stability. Consistent with other results in this study, Na fed PI31
mutant larva have decrease proteasome amounts and activity suggesting this condition may be
toxic (Figure 3.4b). Thus, the increase in proteasome assembly seen with NAD+
supplementation is dependent on the presence of dmPI31 and could be through a mechanism that
enhances proteasome stability.
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Figure 3.4 26S proteasome assembly increases upon NAD+ repletion
(a) Proteasome complexes from head lysates from male and female flies fed NAD+ precursors
for 10 days PE were resolve in their native assemblies. Blotting for anti-alpha7, a 20S
proteasome subunit, labels the 20S CP as well as single capped (RPCP) and double capped
(RP2CP) proteasomes. Upon feeding with NAD+ precursors, 26S proteasome assembly is
increased compared to control. (a’) Nam 20mM and Na 10mM showed the greatest increase in
26S assembly compared to controls while Na 10mM and Na 20mM show the greatest increase in
26S/20S ratio. (a) Using a fluorogenic peptide (LLVY-AMC), the activity of resolved
proteasomes can be assayed in-gel and activities resulting from single capped versus double
capped proteasomes determined. 26S proteasomes are more active compared to control in head
lysates from flies that were fed on Nam 20mM and Na 10mM consistent with these
concentrations increasing 26S assembly. 20S proteasome activity in-gel can also be assayed with
the addition of 0.02% SDS, which opens the “gate” of the core particle to allow entry of
substrates. Nam 20mM and Na 10mM again show the greatest increase in 20S activity compared
to control. (b) DmPI31 null mutant larva were lysed and proteins resolved in their native
conformation to assay proteasome complexes after feeding on NAD+ precursors. DmPI31
mutants show less double capped 26S proteasomes and also show a smaller intermediary form
that still maintains catalytic activity. (b’) 26S proteasome amounts do not change significantly
between control and Nam fed lines. (b) In-gel activity assays show 26S proteasome activity does
not increase upon feeding but Na 10mM shows reduced activity. 20S proteasomes under control
fed larval lack 20S activity but upon feeding 20S activity is restored, this could be due to
insufficient gate opening.
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3.3.4 Mutations in Nmnat, an essential NAD+ synthase, cause defects in proteasome activity
To validate that NAD+ levels play a role in regulating DmPI31 levels, I genetically
targeted the NAD+ salvage pathway using mutants for Nmnat, an essential enzyme that catalyzes
the final step in NAD+ synthesis (Figure 1.3). Nmnat mutants are lethal before the 1st instar
larval stage so mitotic clones were generated in the eye using an eye specific flippase. These
clones reveal a marked decrease in DmPI31 levels in both 3rd instar larvae and adult stages, with
photoreceptor axons beginning to degenerate in adults (Figure 3.5a-b). Published reports have
indicated that Nmnat mutant photoreceptor clones do not display any developmental defects.
Instead, aged and light stimulated retina show progressive degeneration that can be significantly
suppressed in flies that are dark reared (Zhai et al., 2006). Thus, loss of dmPI31 likely proceeds
axon degeneration and is a possible mechanism by which protein load exceeds protein
degradation and leads to degeneration. Upon overexpression of Nmnat in the Nmnat mutant
background, dmPI31 expression levels are rescued (Figure 3.5c) indicating Nmnat levels are
important for dmPI31 expression. To test whether loss of Nmnat results in defective proteasome
activity, I again subject fly lysates to the in vitro proteasome activity assay. Using the TubulinGal4, Tubulin-Gal80 temperature sensitive driver various transgenes were driven in the whole
body of flies at 25°C. RNAi mediated knockdown of PI31, TNKS, and Nmnat decreased
proteasome activity but neither PI31 nor Nmnat overexpression increased proteasome activity
compared to control at this temperature. The proteasome inhibitor MG132 was used to control
for proteasome specific activity (Figure 3.6a). These results suggest that loss of Nmnat results in
decrease proteasome activity which may be due to loss of dmPI31 expression. To test this result, flies
co-expressing UAS-PI31 and UAS-RNAi-Nmnat in Drosophila eye under the GMR-Gal4 driver
were dissected and stained for levels of HA-PI31. Consistent with the Nmnat mutant clone results,
loss of Nmnat leads to decreased dmPI31 expression while photoreceptor axons remain intact (Figure
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3.6b). To determine whether Nmnat alone is sufficient to increase proteasome activity, I tested
whether Nmnat overexpression could rescue proteasome impairment caused by mutant proteasome
subunits DTS5 and DTS7. At high temperatures, these mutants are dominant and inhibit proteasome
activity leading to a rough eye phenotype (Figure 3.7a), which can be rescued by overexpression of
dmPI31 (Figure 3.7b). Overexpression of Nmnat suppresses the decreased size of the eye caused by
DTS5/DTS7 but the external eye morphology remains rough (Figure 3.7c). In addition, feeding
30mM Na is not sufficient to alter the external rough eye phenotype (Figure 3.7f). Neither RNAi nor
enzymatically inactive Nmnat suppressed the phenotype (Figure 3.7d,e) suggesting either that NAD+
levels are not sufficiently enhanced or that DTS5/DTS7 mutant proteasomes do not require ADPriboslyated PI31. Indeed, overexpression of PI31DHbYX in this mutant background rescues the
DTS5 phenotype (not shown), suggesting that TNKS-mediated ADP-ribosylation is not needed or
that TNKS can bind PI31 in vivo independent of the HbYX motif.
To determine whether the loss of PI31 seen with loss of Nmnat is due to a physical interaction,
I cloned FLAG-tagged NmnatC and HA tagged-dmPI31 and transfected them in human 293 cells.
Total lysate when blotted for either HA or FLAG showed successful expression of these plasmids
(Figure 3.8). However, upon IP with HA to pull down PI31 no FLAG antibody was detected in the
pull down (Figure 3.8) indicating that PI31 and NmnatC do not interact under these conditions.
However, there are two other major isoforms of Nmnat that should also be tested that differ in the
splicing of the last 3 exons and have been shown to localize to distinct cellular compartments.
Isoform PD, which is cytoplasmic is shown to have refolding chaperone-like properties and suppress
the neurodegeneration caused by polyglutamine expanded ataxin-1 (Ruan et al., 2015). Since, no
physical interaction was observed I tested whether loss of NAD+ is contributing to loss of dmPI31 in
the Nmnat mutant clones. By feeding flies with Nmnat photoreceptor clones either 20mM or 40mM
nicotinamide, I observe an increase in mean HA-PI31 expression in mutant clones (Figure 3.9a).
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Several clonal patches were tested for each condition and this increase is shown to be significant and
dose dependent (Wild-type control fed: 31.32 +/- 2.61 RFU; Nmnat clone control fed: 16.08 +/- 0.92
RFU, ***p=8.6x10-5; Nmnat clone Nam 20: 19.07 +/- 1.01, *p=0.04; Nmnat clone Nam 40: 20.57 +/1.21 RFU, **p=0.007) (Figure 3.9b). Since, Nmnat mutants still produce a truncated form of the
protein that has the NMN binding domain in the N-terminus intact it is possible that residual activity
is still present. However, a functional null allele with the first 4 exons deleted was also tested and
still caused the loss of dmPI31 expression (not shown). Whether DmPI31 expression can be rescued
with NAD+ supplementation in these clones has not yet been tested. This future experiment could
determine whether the loss of DmPI31 is dependent on NAD+ synthesis, shared intermediate binding
to Nmnat, or a general stress response by affected neurons.
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Figure 3.5 Nmnat mutants display less dmPI31 in photoreceptor cells
Mosaic clones of mutant Nmnat1 were generated in the Drosophila larval eye discs and adult
photoreceptor axons by driving eye specific flippase. (a) HA tagged PI31 was driven in 3rd instar
larva eye discs under the GMR-Gal4 driver. Nmnat mutant clones, outlined in red, show less
HA-PI31 expression although Nmnat clones do not show any developmental defects. (b) Adult
optic lobes with Nmnat1 mutant clones boxed in yellow. These clones display signs of axon
degeneration at 20 days PE accompanied by less HA-PI31 expression (white). Staining with antichaoptin (green) marks all R7/R8 photoreceptor axons while dsRed marks only wild-type clones.
(c) Optic lobes with mosaic clones of mutant Nmnat1 in 25 day old flies generated using eyelessflippase. HA-PI31 expression can be rescued in Nmnat1 mutant clones, boxed in yellow, by
overexpression of Nmnat driven by GMR-Gal4.
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Figure 3.6 Knockdown of Nmnat leads to defects in proteasome activity
(a) In vitro proteasome activity assay on whole fly lysates from lines expressing indicated
transgenes under Tubulin-Gal4, Tubulin-Gal80 temperature sensitive driver at 25°C. RNAi
mediated knockdown of PI31, TNKS, and Nmnat decreased proteasome activity. Neither PI31
nor Nmnat overexpression increased proteasome activity compared to control. The proteasome
inhibitor MG132 was used to control for proteasome specific activity. (b) Confocal images of
optic lobe z-projections from flies UAS- PI31 lines and lines co-expressing UAS-PI31 and UASRNAi-Nmnat under the GMR-Gal4 driver. DmPI31 expression is decreased in Nmnat
knockdown background while photoreceptor axons remain intact as indicated by anti-24B10
(red) staining.
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Figure 3.7 Nmnat is sufficient to suppress eye phenotypes caused by mutant proteasomes
(a) Eye phenotypes from female flies expressing the temperature sensitive DTS5 and DTS7
mutations in the proteasome under the GMR-Gal4 driver at 28.6°C. (a) These mutations are
dominant and inhibit proteasome activity leading to a rough eye phenotype. (b) Overexpression
of dmPI31 in this background rescues this eye phenotype. (c) Overexpression of Nmnat in this
background suppresses the eye phenotypes and the size of the eye increases but the morphology
remains rough. (d) Enzymatically inactive Nmnat.WR and (e) RNAi for Nmnat do not show
significant difference in eye morphology compared to DTS5/DTS7 background. (f) Feeding
DTS5/DTS7 flies throughout development on Na 30mM is not sufficient to alter the external
rough eye phenotype.

78

Figure 3.8 DmPI31 does not show a physical interaction with NmnatC
Human 293 cells were transfected with either FLAG-tagged NmnatC isoform, HA taggeddmPI31, or co-transfected. Total lysate input blotted for HA shows expression of HA-PI31 in
cells transfected with HA-PI31 alone or co-transfected with NmnatC. Blotting against anti-Flag
shows expression after transfection of Nmnat in total lysates. Using HA magnetic beads, HAPI31 was pulled down however, no Flag tagged protein was detected to co-IP with HA-PI31,
suggesting PI31 does not physically interact with NmnatC. However, PI31 is known to be
cleaved at its C-terminus and NmnatC may be protecting PI31 from this cleavage.
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a.

Figure 3.9 Nam partially rescues dmPI31 expression in photoreceptor axons
(a) Mosaic clones of mutant Nmnat1 were generated in the Drosophila adult photoreceptor axons
by driving eye specific flippase. These flies were put on 20mM or 40mM Nam supplemented
instant food at 1 day PE and flipped once to new food before dissection at 10 days PE. Nmnat
mutant clones show less HA-PI31 expression that can be significantly increased upon feeding
with increasing amounts of Nam. (b) Quantification of HA-PI31 fluorescent signal in wild type
versus Nmnat mutant clones fed on control or Nam supplemented diets. A significant increase in
seen upon supplementation of both Nam 20mM and Nam 40mM. (Wild-type control fed: 31.32
+/- 2.61 RFU; Nmnat clone control fed: 16.08 +/- 0.92 RFU, ***p=8.6x10-5; Nmnat clone Nam 20:
19.07 +/- 1.01, *p=0.04; Nmnat clone Nam 40: 20.57 +/- 1.21 RFU, **p=0.007)
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3.4 Discussion
Both NAD+ levels and proteasome assembly have been shown to decline with age
((Tonoki et al., 2009; Gomes et al., 2013). This connection suggests a hypothesis whereby loss of
NAD+ during aging can decrease proteasome activity and lead to the accumulation of abnormal
proteins seen in aging and age-related disorders. It’s intriguing to think of proteasomes in direct
communication with the metabolic status of the cell via NAD+ dependent ADP-ribosylation of
dmPI31. In a means to test this hypothesis, I have found that NAD+ precursors can increase
proteasome activity, dmPI31 protein levels, and proteasome assembly. The activity of the
proteasome under NAD+ supplementation is dependent on expression of full length PI31 as
knockdown of PI31 or overexpression of PI31DHbYX does not cause significant changes
between fed states. However, attempts to pull down the ADP-ribosylated form of dmPI31 in
adult flies were not successful. This could be due to technical difficulties but more intriguingly
may mean that this modification is only abundant during specific developmental time points and
possibly localized to distinct subcellular locations in discreet amounts ie possibly at the synapse.
In this way, ADP-ribosylation of DmPI31 could serve as a metabolic switch to regulate
proteasome activity in different cellular compartments based on the local NAD+ pools available.
In fact, NAD+ in not able to move between compartments (van Roermund et al., 1995) and
different NAD+ pools have been shown to behave independently of one another to maintain
cellular homeostasis after stress (Yang et al., 2007). However, until recently tools to study the
subcellular distribution of distinct NAD+ pools were lacking or relied on NAD+ consumption by
PARP1 as a read out (Dölle et al., 2009; Hung et al., 2011; Cambronne et al., 2016; VanLinden
et al., 2017). These tools can now be adapted to Drosophila and used alongside existing tools to
measure proteasome activity in vivo to determine the affect of subcellular NAD+ pools on
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proteasome activity.
The finding that dietary restriction (DR) is also able to increase proteasome activity in vitro
and increase DmPI31 expression in the larval brain is in line with DR increasing NAD+ levels. I
find that proteasome activity is not significantly altered in the brain compared to whole body.
Similarly, other studies have found that 26S proteasome activity is lower in the brain than liver,
brain proteasomes display less plasticity, and DR preserves 26S proteasome activity (Dasuri et
al., 2009). This is intriguing since DR is the only non-genetic way to extend lifespan across
several species. These results point to a quality control mechanism that is preserved with age
during increased states of NAD+ to maintain proteostasis. Our findings that the essential
neuronal maintenance factor, Nmnat, regulates DmPI31 protein levels in vivo, does not interact
with dmPI31, and does not itself significantly impact proteasome function point to a signaling
pathway or intermediate binding partner. Indeed, evidence points to a signaling event mediated
by NAD+ as NAD+ supplementation can increase DmPI31 levels in an Nmnat mutant
background. The recovery of DmPI31 could also be due to increased health of the axons
provided by NAD+ in a pathway different than that of Nmnat.
NAD+ in addition to being a substrate for NAD+ consuming enzymes also plays a major
role in redox reactions involved in cellular respiration. Although I find that NAD+ increases
proteasome activity, DmPI31, and proteasome assembly, I cannot rule out the possibility that
these effects are mediated through the generation of more ATP. 26S proteasome mediated
degradation is an ATP dependent process requiring ATP during ubiquitination of substrates,
substrate unfolding, substrate hydrolysis, and 26S assembly (Majetschak, 2013). However, the
reduced form of NAD+, NADH has been shown to bind directly to 26S proteasomes via a
putative NADH binding motif (GxGxxG) and maintain their stability independent of ATP. It is
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also possible that feeding NAD+ precursors increases NADH in the cell and contributes to
increased proteasome assembly by maintaining 26S proteasome integrity (Tsvetkov et al., 2014).
The sum of these findings indicate that 26S proteasomes are metabolically regulated and that
contexts where NAD+ levels are compromised could lead to insufficient proteasome activity that
manifests in various phenotypes such as aging and neurodegeneration.

3.5 Materials and Methods
Fly stocks and recipes for nutrient supplementation
Oregon-R and w1118 flies were used as controls. Hs-NintraEGFP, DTS5, and DTS7 were given as
kind gifts by John Belote. All Nmnat stocks were generated by Hugo Bellen’s lab and deposited
in Bloomington with stock numbers Nmnat.WR (39700), Nmnat (39699), NmnatRNAi (29402).
Fly food was generated by adding 36g Baker’s dried active yeast, 87.5 g corn meal, and 10g agar
to 1.2L distilled H20. Mixture was boiled for 10min to allow agar to dissolve and then 83ml of
molasses was added and mixture was allowed to boil for 10 additional minutes with continuous
stirring. While stirring food was cooled to 65°C and 8.3mL 30% Tegosept and 0.89mL propionic
acid were added along with indicated concentration of Na or Nam. Food was aliquoted into
empty fly vials and allowed to solidify and cool to room temperature before flies were
distributed onto food. Extra food was stored at 4°C until needed and brought to room
temperature prior to addition of flies. All lines were grown at 25°C in a 12hr light/dark cycle
incubator.
In vitro proteasome activity assay
Heads or whole-body tissue samples from indicated genotypes were prepared in PIPES lysis
buffer (50mM PIPES, 1mM MgCl2, 50mM NaCl2, 2mM EGTA, and 2mM fresh ATP) by
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homogenizing tissue using pellet pestle motor and spinning samples in table top centrifuge for
20min at 4°C. Supernatant was taken and protein concentration measured with BCA assay
(Pierce BCA Protein Assay Kit- Thermo Scientific). 50-75ug of protein was mixed at a 1:1 ratio
with the Proteasome-Glo chymotrypsin reagent (Promega G8621) according to manufacture
details. MG132 (UBPBio, F1101), a proteasome inhibitor, was incubated with control samples as
a readout for proteasome specific signal. Reactions were done in triplicate in a 96 well plate and
read on Spectramax M-2 microplate reader. Statistical analysis was done by averaging
experimental replicates, normalizing to controls, and taking activity as a percentage of control
over several assays. Error bars represent 7 separate experiments all normalized to their respective
controls.

In vivo proteasome activity assay and immunostaining
To assess the in vivo activity of the proteasome, degradation of EGFP-Nintra was monitored in the
presence of dominant proteasome subunit mutants. Hs-EGFP-Nintra lines were crossed to UASDTS7 and propagated for a stable line. These lines were fed Na 30mM and late 3rd instar were
heat shocked by placing larva in an Eppendorf tube in a 37°C water bath for 30min. Larva were
then placed at 25°C and allowed to recover for 1 hour before dissection and fixation. Tissues
were mounted with Vectashield plus DAPI and imaged on the confocal microscope. Statistical
analysis was done by measuring fluorescence intensity in ImageJ and comparing control non fed
vs fed larva.
Native gels and in gel peptidase activity
Head or whole body lysates were homogenized using a pellet pestle motor in native lysis buffer
(50mM Tris- HCL pH 8.0, 5mM MgCl2, 0.5mM EDTA, and fresh 2mM ATP, 0.2% NP40,
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Protease inhibitor cocktail (Roche, 11873580001) and phosphatase inhibitor (ThermoFisher
Scientific 78442). Samples were spun down at 4°C in table top centrifuge at max speed and
supernatant was taken and measure for protein concentration using BCA assay. Native running
buffer was prepared as followed and cooled to 4°C (450mM Tris, 450mM Boric acid, 5mM
EDTA, and 25mM MgCl2, 0.5mM ATP, and 0.5mM DTT). 40ug of samples were loaded 1:1
with native sample buffer (Bio-Rad, 161-0738) onto 3-8% Criterion XT Tris-Acetate Gels along
with 3ug purified bovine 19S (A1301), 20S (A1401), and 26S (A1201) as loading controls from
UBPBio. Electrophoresis was carried out for 1 hour at RT at 50V and then continued at 4°C for 6
hours at 120V. Protein transfer was done using PVDF 0.45um pore membranes (Millipore) in
Tris-Glycine buffer without methanol for 3hours at 12V at RT using Genie Electrophoretic
Transfer apparatus. Afterward, membranes were blocked with 5% milk in PBST (Tween-20)
overnight at 4°C. Membranes were incubated with primary antibodies anti-alpha7 (1:500) aRpt3(1:500) both from Enzo for 1 hour at RT, washed 3X, and incubated with secondary
antibody a-mouse-HRP (1:2500), then washed 3X. Membranes were developed using Western
Lighting ECL blotting reagent (Perkin Elmer) using Kodak Biomax MR film.
For native in-gel activity assays, native gels were run to completion but before transfer were
washed with Buffer A (50mM Tris-HCl ph 7.5, 150mM NaCl, 5mM MgCl2, 10% glycerol) and
the incubated with developing buffer (50mM Tris-HCl ph 7.5, 150mM NaCl, 5mM MgCl2, 1mM
ATP, 100uM Suc-LLVY-AMC) at 30°C for 30min with light shaking. Gel was exposed to
illumination at 365nm and imaged using iPhone 6. To assay 20S CP activity gel was exposed to
developing buffer plus the addition of 20% SDS for 30min at 30°C. Visualized again at 365nm
and then washed with buffer A before transfer proceeded.
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Western blotting
Protein samples from either in vitro activity assays or native gel analysis were taken and 20ug of
protein loaded with 10uL of SDS red loading buffer. Proteins were resolved on 4-20% miniprotean TGX precast gels and electrophoresis was carried out for 1.5hour at 100V. Transfer was
done using PVDF membrane 0.45um pore size in Tris-Glycine buffer plus 20% methanol for
1.5hour at 100V in 4°C. Membranes were blocked in 5% milk and stained with primary
antibodies, a-tubulin (1:1000) or a-bactin (1:1000) for 1hour, washed 3X, incubated with
secondary, and developed using ECL Western blotting detection reagent.

Cell culture of S2 cells and HEK293 cells
S2 cells were grown at RT in sterile conditions using Schneider’s cell medium with 10% heat
inactivated FBS, and antibiotics. Cells were split periodically. Before transient transfection cells
were split to 70% confluency and lipofectamine and recombinant DNA of GST-PI31 given as a
gift by Yetis Gultekin, were allowed to incubate and form complexes for 30min at RT. In the
meantime, S2 cells were put in serum free low antibiotic and transfection reagent was added
dropwise all over petri dish with cells. This was incubated for 4 hours at which point cells were
incubated with fresh media.

Nmnat and dmPI31 co-immunoprecipitation
TOPO cloning was used to generate plasmids and transfect them into HEK 293 cells. Cationic
lipid reagent (20 µl of Lipofectamine 2000; Invitrogen) was diluted in serum-free media (OptiMEM; Invitrogen) for transfection in HEK293 cells (100 mm dish). Following a 5 hr incubation,
the medium was replaced with Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented

86

with 10% fetal bovine serum (FBS). Transfected cells were harvested in PBS 48 hr following the
addition of serum-containing media. The cells were then lysed by repeated freeze/thaw cycles in
600 µl of lysis buffer (20 mM HEPES-KOH [pH 7.6], 200 mM KCl, 0.5mM EDTA, 10%
glycerol, 1% Triton X-100 and protease inhibitor cocktail [Complete; Roche]) that contained
RNase A (50 µg/ml; Sigma-Aldrich). Cell debris was pelleted by centrifugation, and the protein
concentration in the supernatant was determined with the Bio-Rad assay. Primers for NmnatC
isoform that were used are as follows F-ATGATTGTGAAAATCAGCTGGC and RCTAAAGTTGCACTTGGGAAATC with Flag tag GACTACAAAGACGATGACGACAAG.
HA- PI31 plasmid was a gift from Yetis Gultekin.

Brain dissections and immunofluorescence
GMR Gal4, eyFLP;sco/scyo;FRT82B dsRED lines were crossed with either FRT82B Nmnat1
(24886) or FRT82B NmnatD4790-1 (39698) and mitotic clones were generated in the photoreceptor
axons and PE flies were fed C, 20mM Nam, or 40mM Nam supplemented instant Drosophila
medium plus yeast for 10 days. Adult brains where dissected and fixed in 4% PFA for 40min and
blocked in 2% BSA. Primary antibody a-mouse HA (1:1000, Sigma) was used for incubation at
4°C overnight, tissues were washed 3X in PBST, and secondary Donkey anti-mouse FITC
(1:500) was added and incubated for 4 hours at 4°C. Tissues were washed 3X and mounted in
Vectashield plus DAPI before being imaged on Zeiss confocal microscope at 63X.
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4. DmPI31 increases proteasome activity to suppress degeneration in a
Drosophila model for Spinocerebellar Ataxia-Type 1 (SCA1)

4.1 Summary
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Huntington’s, and Spinocerebellar
ataxias (SCAs) share a characteristic feature, the accumulation of ubiquitin-conjugated proteins
into aggregates. This suggests that the affected neurons initiated clearance of abnormal proteins
by tagging with ubiquitin, but proteasome-mediated degradation subsequently failed. In this
chapter, I explore the impact of upregulating proteasomes via the DmPI31 pathway on
neurodegeneration in the poly-glutamine disease, Spinocerebellar Ataxia Type-1(SCA1). Using a
Drosophila model for SCA1 that expresses human ataxin-1 with an extended 82 glutamine
repeat (hAtx-1[82Q]), I demonstrate that poly-ubiquitinated proteins do indeed accumulate in
this model and that DmPI31 and NAD+ repletion are sufficient to suppress this accumulation.
Additionally, DmPI31 alleviates degenerative phenotypes associated with overexpression of
hAtx-1[82Q] in the eye. Lastly, I explore the possibility that dmPI31 rescues these phenotypes
by altering the localization of proteasomes. These studies suggest that dmPI31 may be a
therapeutically promising target for the treatment of neurodegenerative diseases.

4.2 Rationale
The autosomal dominant poly-glutamine disease, Spinocerebellar ataxia type-1(SCA1), is the
result of an abnormal CAG trinucleotide repeat of 39 or more in the ATXN1 gene. ATXN1 is
conserved across several species including humans, mice, and Drosophila but its exact function
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is unknown. It is clear however, that the mutant ataxin-1 protein accumulates into nuclear
inclusions along with Hsp70, ubiquitin, and proteasomes in SCA1 (Cummings et al., 1998;
Fernandez-Funez et al., 2000). Furthermore, selective degradation of mutant ataxin-1 requires
the ubiquitin-proteasome pathway (Fernandez-Funez et al., 2000; Lee and Goldberg, 2010;
Persengiev et al., 2012). Using a short lived enhanced green fluorescent protein (d2EGFP), one
group showed that mutant ataxin-1(82Q) causes d2EGFP to accumulate as the result of
proteasome impairment (Park et al., 2005). In Drosophila, proteasome impairment by the
dominant temperature sensitive Pros26.1 mutation (DTS5), enhances the neurodegeneration
caused by expanded ataxin-1. However, whether other proteasome subunits and interactors can
modify SCA1 phenotypes is unknown, since much of the work is focused around ubiquitin-like
modifiers and chaperones (Ding et al., 2016; Lee and Goldberg, 2010; Nagashima et al., 2011;
Parfitt et al., 2009). One protein that was found to act as a chaperone and ameliorate SCA1
induced neurodegeneration in Drosophila is NMNAT. Overexpression of NMNAT or enzymeinactive NMNAT (NMNAT-WR) partially suppressed the degenerative phenotypes produced
hAtx-1[82Q] and are recruited to aggregates in vivo. Still, in cultured cells insoluble aggregates
accumulate upon treatment with the proteasome inhibitor, MG132. These aggregates still
accumulate when co-transfected with NMNAT in the presence of MG132, although at lower
levels (Zhai et al., 2008). This points to NMNAT promoting hAtx-1[82Q] degradation at least
partially through a proteasome-mediated pathway.
In the previous chapter, I showed that NMNAT can modulate both proteasome activity and
DmPI31 levels. Thus, I hypothesized that DmPI31 may also act to partially suppress
neurodegeneration in SCA1 flies. Here, I describe the suppression of poly-ubiquitinated
proteins and degenerative phenotypes in SCA1 by overexpression of DmPI31. I investigate
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whether this suppression is through increased activity of proteasomes, increased degradation of
hAtx-1[82Q], or localization. The results point toward increased hAtx-1[82q] degradation and
localalization of proteasomes being key. In addition, I show that NAD+ repletion is also able to
reduce the accumulation of poly-ubiquitinated proteins and this suggests a possible parallel
pathway that works in addition to enzymatically inactive NMNAT to reduce SCA1 toxicity.

4.3 Results
4.3.1 DmPI31 suppresses toxicity induced by human Ataxin-1
The established model for SCA1 in Drosophila was generated by cloning SCA1 cDNAs
differing in the length of their poly-glutamine expansion into the Drosophila pUAST vector.
These cDNAs encode for full length human ataxin-1 with either a 30-glutamine repeat (wild-type
isoform) or an 82-glutamine expansion (disease relevant isoform). Both transgenic lines result in
progressive neurodegenerative phenotypes although the severity is diminished and time of onset
delayed in hAtx-1[30Q]. Moreover, wild-type Drosophila ataxin-1 (dAtx-1) overexpressed under
UAS control in the retina results in a rough eye phenotype, pointing to the amount of
accumulated ataxin-1 being significant for disease phenotypes in addition to glutamine repeat
length (Fernandez-Funez et al., 2000; Zhai et al., 2008).
Here, my goal was to determine whether overexpression of DmPI31 is sufficient to lessen
the burden of ataxin-1 accumulation in SCA1 through increased proteasome activity. Using the
Gal4/UAS system, I drove expression of four different ataxin-1 transgenes in the Drosophila
retina under the glass multimer reporter (GMR). Consistent with previous reports, I show that
overexpression of dAtx-1 results in a rough eye phenotype that is rescued with overexpression of
NMNAT (Figure 4.1a) (Zhai et al., 2008). Overexpressing both full-length DmPI31 and C-
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terminal truncated dmPI31DHbYX rescued the small and rough eye phenotype caused by dAtx1(Figure 4.1a) in a manner comparable to NMNAT. Similarly, both DmPI31 and
DmPI31DHbYX were able to rescue the rough eye phenotype caused by overexpression of hAtx1[30Q] (Figure 4.1b). Two transgenic lines for hAtx-1[82Q] with different chromosomal
insertions were used to test whether DmPI31 was sufficient to rescue the severe eye phenotypes
caused by the expanded human isoform. Both lines cause a severe degenerative phenotype but
hAtx-1[82Q] on the 3rd chromosome gives a more severe phenotype than the insertion on the X
chromosome. However, DmPI31 and DmPI31DHbYX are able to improve the external retinal
phenotypes in both cases comparable to overexpression of NMNAT. It is of note that
PI31DHbYX contributes to an enhanced suppression compared to full length DmPI31. This may
be due to lower expression levels of the truncated form since another DmPI31 insertion (10a)
that is expressed at low levels shows even further suppression (Figure 4.1d). The HbYX domain
at the C-terminal end of DmPI31 is thought to operate by allowing DmPI31 to dock onto 20S
proteasomes in a manner similar to the HbYX motifs used by proteasome activators (Smith et al.,
2007b; Kusmierczyk et al., 2011). This motif was also shown to be essential for full 26S
activation conferred by DmPI31 and be necessary for TNKS and 19S assembly chaperone
binding to DmPI31 (Bader et al., 2011; Cho-Park and Steller, 2013). So, how does the HbYX
deleted DmPI31 lead to more suppression rather than an enhancement of the retinal phenotype?
To better understand this phenotype, I tested knockdown of TNKS in the hAtx-1[82Q]
background. Using a UAS driven RNAi for TNKS, the phenotype of the retinae is aggravated
with many more necrotic spots consistent with reports that TNKS knockdown enhances
proteasome inhibition. Surprisingly, RNAi of PI31 suppresses toxicity of SCA1 counter to its
role as a proteasome activator. This may be due to incomplete knockdown of PI31 and/or a stress
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response that results in more proteasome activity when proteasomes are inhibited (Meiners et al.,
2003). However, rescue of SCA1 retinal phenotype may be dependent on fine-tuned levels of
DmPI31 which may explain why knockdown and an insertion with less expression are able to
enhance suppression. Knockdown of two other proteasome subunits a6 and a7 cause
enhancement of the SCA1 phenotype (not shown). Together, these data show that proteasome
activity is indeed essential for suppressing the toxicity of SCA1 and that the dmPI31/TNKS
pathway positively mediates suppression.
To further validate these findings, I prepared cryostat sections of Drosophila heads for
immunofluorescence detection of retinal structures. 10um slices of whole heads were taken and
stained for anti-chaoptin (24b10) to mark photoreceptors, anti-HA, and DAPI to label DNA in
nuclei. Consistent with published data, SCA1 causes severe retinal degeneration see in the
internal structure resulting in collapse of the retina and short disorganized photoreceptor staining
(Figure 4.2b). Overexpressing DmPI31 in this background does not rescue retinal collapse but
organization of photoreceptors is slightly improved (Figure 4.2c). In these sections
overexpressed DmPI31 is seen to localize primarily in the retina and lamina in distinct puncta
but also shows some expression in the R7 and R8 photoreceptor axons. Similar to the
improvement in eternal eye morphology DmPI31DHbYX shows a slight improvement in retinal
collapse with photoreceptor organization appearing more organized compared to hAtx-1[82Q]
(Figure 4.2d). To better assay degeneration in the eye, I prepared whole mount retinal dissections
and visualized photoreceptors by staining with rhodopsin-1 or armadillo, the Drosophila
homolog of bcatenin, and phalloidin, to label F-actin rich rhabdomeres. Preliminary results of
confocal z-stack projections show that overexpression of hAtx-1[82Q] causes rhadomeres to
degenerate as early as 4 days post eclosion. Staining with phalloidin shows rhabodmere
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disorganization and loss while anti-armadillo, which stains cell membranes, reveals the extent of
disorganization. Bristle cells and pigment cells are cluster together, membranes are not
continuous, and many cells appear to have burst (Figure 4.3a). Overexpression of DmPI31
rescued some of the disorganization and rhabdomere loss as indicated by phalloidin staining.
Staining with armadillo still revealed disruptions in membrane structure and pigment cell
degeneration however, overall membrane structure was improved (Figure 4.3b). Thus, taken
together these results indicate that although some degeneration is still present, overexpression of
dmPI31 in the Ataxin-1[82Q] mutant background can suppress disruptions in rhabodmere
organization. The physiological consequences of this improvement are still being explored.
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Figure 4.1.DmPI31 overexpression partially suppresses degenerative phenotypes in a
Drosophila model for SCA1
Eye exterior morphology (a-d) of flies overexpressing (a) wild-type Drosophila Atx-1, (b) wildtype human ataxin-1 with a 30Q repeat, (c) 82Q expanded mutant human ataxin-1 on the 3rd
chromosomes and (d) 82Q human ataxin-1 on the X chromosome. In each case, dmPI31
overexpression suppresses the phenotypes along with dmPI31DHbYX comparable to
overexpression of NMNAT. Interestingly, (c) RNAi for TNKS show enhanced toxicity while
RNAi for PI31 appears to suppress toxicity. (d) Lowered expression of full length dmPI31 also
enhances suppression of mutant eye phenotype cause by hAtx-1[82Q] which may point to
compensatory mechanisms being responsible for the eye phenotypes that result from RNAi for
dmPI31.
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Figure 4.2. Retinal sections reveal partial suppression of ataxin-1 internal eye degeneration
by dmPI31
(a-d) 10um frozen sections from Drosophila retina were stained with chaoptin (red) and (a)RH-1
or (b-d) anti-HA. Vertical sections show marked degeneration of rhabdomeres in lines
overexpressing (b) hAtx-1[82] that can be partially suppressed with overexpression of (c) full
length HA-dmPI31, which results in more organized rhabdomeres. HA staining shows dmPI31
localizes highly in the retina, lamina, and R7/R8 photoreceptor axons. (d) Overexpression of
HA-PI31DHbYX shows even more suppression with some rhabdomere length returning and
improved organization. Images are taken at 63X or 20X where indicated.
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a.

b.

Figure 4.3 DmPI31 suppresses photoreceptor degeneration and improves retinal
organization
(a-b) 4-day old whole mount retina were stained for phalloidin (purple) and anti-armadillo
(green) to mark rhabdomeres and cell membranes respectively. (a) In hAtx-1[82Q] retina,
ommatidial organization is severely affected and rhabdomeres are shown to degenerate as in
indicated by lack of phalloidin staining. Bristle and pigment cells also cluster and many cells
show a “burst” phenotype (see white arrow). (b) Overexpression of dmPI31 results in an
improvement in the organization of the retina as indicated by phalloidin staining. However,
armadillo staining shows pigment and bristle cells are still unorganized and degenerate as well as
the persistence of the “burst” phenotype seen with expanded ataxin alone.
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4.3.2 DmPI31 increases degradation of polyubiquitinated proteins in a Drosophila model
for SCA1
To determine whether proteasome activity is enhanced in SCA1 flies expressing dmPI31, I
first assayed whether polyubiquitinated proteins faithfully accumulate in the SCA1 mutant
background. To do this, whole mount brains were dissected and stained for conjugated ubiquitin
(anti-FK2) as a readout of proteasome activity. In SCA1 mutants, FK2 accumulates compared to
GMRGal4 control indicating a defect in proteasome mediated degradation consistent with other
reports (Figure 4.4a,b). Co-expression with either dmPI31 or dmPI31DHbYX reduced FK2
staining to near control levels (Figure 4.3c,d). ImageJ was used to quantify the fluorescence
intensity relative to the area for each genotype and the reduction in FK2 staining in the dmPI31
and dmPI31DHbYX background are shown to be significant (Figure 4.4e). The majority of FK2
accumulates in the cells of the medulla cortex but can also be seen in the R7 and R8
photoreceptor axons.
How does DmPI31 mediated clearance of ubiquitinated proteins in SCA1? It could be that
enhanced assembly of 26S proteasomes mediates clearance of toxic hAtx-1[82]. This does not
give a simple explanation for the increased rescue seen when overexpressing PI31DHbYX, since
TNKS and 19S assembly chaperone binding require the HbYX domain (Cho-Park and Steller,
2013). To determine the extent of hAtx-1[82Q] clearance, head lysates were resolved on SDSPAGE gel and subject to western blot analysis. Anti-atxain 1 antibody showed a slight
accumulation compared to no expression control in fly lysates overexpressing the human
expanded protein (Figure 4.5a). The band that is seen in control is likely due to the antibody
recognizing endogenous Drosophila ataxin-1. In lysates that overexpress PI31, ataxin-1 levels
are modestly reduced which can account for the lower levels of poly-ub proteins that are seen in
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vivo. However, PI31DHbYX which showed a stronger suppression of FK2 did not show
reductions in Atx-1 levels. The a7 subunit of the proteasome does not show a change in
expression levels between expanded ataxin-1 alone or with the PI31 transgenes (Figure 4.5a). To
address whether proteasome assembly is affected, I turned to native gel analysis to determine
whether changes in proteasome assembly could account for the rescue. Preliminary results show
no significant difference in proteasome assembly in head lysates from 25 day old flies (Figure
4.5b). The amount of proteasome activity assayed by in gel activity showed no difference
between hAtx-1[82Q] and those line crossed with PI31 or PI31DHbYX. However, double capped
proteasomes are not detectable at this protein concentration and thus a more concentrated protein
sample may distinguish between different amounts of assembly.
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Figure 4.4 DmPI31 relieves the accumulation of polyubiquitinated proteins in SCA1
(a-d) Whole mount adult brains were assayed for the accumulation of ubiquitin conjugated
proteins by staining with FK2 antibody and imaging by confocal microscopy. (a) Control lines
show slight accumulation of FK2 and HA autofluorescent signal with (b) marked accumulation
of FK2 in the hAtx-1[82Q] overexpression background. (c) Co-expression of HA-PI31 or (d)
HA-PI31DHbYX significantly reduces the accumulation of FK2. (c) HA-PI31 is highly
expressed in the R7/R8 photoreceptor axons while HA-PI31DHbYX is not expressed at high
levels. (e) Quantification of FK2 signal in z-projections of the optic lobe. Bars represent the
corrected total fluorescence and statistical analysis was carried out on a total of 5 heads. (GMR
Gal4 : 79348. 8 +/- 6181.3 ; hAtx-1[82Q] :111488.3 +/- 6781.5, p=0.042; PI31 hAtx-1[82Q] :
90821.60 +/-6919.3,*p=0.064; PI31DHbYX hAtx-1[82Q]: 63164.7 +/- 1891, **p=0.0019).
Significance was carried out with a two-tailed, paired, t test.
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Figure 4.5 DmPI31 overexpression causes Atx-1 degradation but not increased proteasome
assembly
(a) Western blot analysis from hAtx-1[82Q] fly head lysates show slight accumulation of atxain1 antibody compared to no expression control at 105kDa. The band that is seen in the control is
likely due to the antibody recognizing endogenous Drosophila ataxin-1. In lysates that
overexpress PI31, ataxin-1 levels are modestly reduced but PI31DHbYX did not reduce Atx-1
levels. Wild-type human ataxin-1[30Q] also shows accumulation but overexpression of dmPI31
alone shows ataxin-1 levels similar to control. The alpha7 subunit of the proteasome does not
show a change in expression levels between expanded ataxin alone or with the dmPI31
transgenes. (b) Native gel analysis of head lysates from 25 day old flies. Blotting with alpha7 or
Rpt3 did not show marked differences between proteasome assembly in any of the cases that
result in partial suppression of SCA1 phenotypes.
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4.3.3 PI31 may alter localization of proteasomes in neurodegenerative models
The suppression of neurodegenerative phenotypes may also depend upon the localization of
mutant proteins, chaperones, and proteasomes. For instant, the neuroprotective ability of Nmnat
in the SCA1 model was found to be the result of different splice variants that translate into
proteins with different localization. The cytoplasmic isoform of Nmnat was found to confer
neuroprotection and is the major splice variant under stress conditions in neurons (Ruan et al.,
2015). PI31 may also alter local proteasome activity and contribute to the suppression of SCA1
phenotypes. In SCA1, it was observed that the GFP tagged alpha2 subunit of the proteasome
displays altered localization compared to controls (Figure 4.6). In controls, a2 appears in puncta
localized near the giant glial cells of the medulla (Figure 4.6a). However, in hAtx-1[82Q] very
few puncta remain possibly pointing to a shift to a more diffuse distribution (Figure 4.6b).
Previous western analysis on these flies did not show a difference between another alpha subunit
a7 thus leading to the interpretation of localization being altered.
In a Drosophila model for Parkinson’s disease (PD), the missense mutations found in asynuclein (A53T, A30P, E46K) that lead to early onset familial PD, lead to similar symptoms in
the fly. These include loss of climbing ability, progressive loss of dopaminergic neurons and the
formation of inclusion bodies (Feany and Bender, 2000). Unpublished data from Dolor Ferres
Marco, a former postdoc in the Steller lab, shows that the progressive loss of climbing ability of
A53T lines can be recused by overexpression of PI31DHbYX but not by full length PI31 (Figure
4.7a). PI31 itself is shown to be essential to maintain climbing ability with age consistent with
previous finding that loss of PI31 results in decreased lifespan (Figure 4.7a orange line). To
determine the cause of this difference between full length and HbYX deleted PI31, I looked at
the localization of both in an A53T a-synuclein background. Expression of all transgenes was
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driven by the pan neuronal driver nervana2. Interestingly, these transgenes show different
localization in the optic lobe of flies. While full length PI31 is expressed at high levels and
mostly nuclear, HbYX deleted PI31 expression is mostly cytoplasmic, similar to the
neuroprotective form of Nmnat (Figure 4.7b-c). More studies within the affected dopaminergic
neurons of this model will need to be tested but these preliminary results point to these two
different transgenes being expressed in different locals which may explain the differences in
neuroprotection seen in PD and SCA1 models. Preliminary results to assay the localization of
PI31 in SCA1 and degradation of hAtx-1[82Q] show that overexpression of full length PI31 is
sufficient to lower total hAtx-1[82Q] accumulation (Figure 4.8). This was expected since
western blot analysis verified decreased expression of hAtx-1[82Q]. However, whether
PI31DHbYX truncated will result in the altered expression of expanded ataxin-1 is yet to be
determined. Western blot results show that hAtx-1[82Q] does not decrease in a PI31DHbYX
background so determining the localization of both proteins may give clues to how PI31DHbYX
confers more protection.
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Figure 4.6 Expanded Atx-1 causes a shift in proteasome localization
(a-b) Whole mount brains expressing the GFP tagged alpha2 subunit of the proteasome under its
endogenous promoter were fixed, stained for FK2, and imaged on a confocal microscope. (a) In
the control optic lobe, alpha2-GFP is highly expressed in distinct cells within the medulla as
puncta. FK2 (red) does not show substantial staining. (b) Upon overexpression of hAtx-1[82Q]
in these lines, FK2 (red) shows marked accumulation in both retina and R7/R8 photoreceptor
axons. Here, alpha2-GFP also becomes localized to the medulla cortex and expression is more
diffuse.
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Figure 4.7 Overexpression of dmPI31DHbYX rescues climbing ability in a Drosophila PD
model and shifts localization of PI31 to the cytoplasm
(a) Climbing assay of Drosophila Parkinson’s disease model expressing the A53T a-synuclein
mutation. These flies (teal) show progressive loss of climbing ability that is rescued with coexpression of PI31DHbYX (light blue). Co-expression with full length PI31 (yellow) did not
rescue the climbing ability and RNAi of PI31 (grey) enhances loss of climbing ability. (b)
Overexpression of full length dmPI31 in the A53T mutant background shows PI31(red) localized
primarily in the nucleus while (c) overexpression of PI31DHbYX shifts localization to the
cytoplasm. GFP marks cells highly expressing nervana-Gal4 driver.
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Figure 4.8 Overexpression of DmPI31 in vivo reduces Atx-1 accumulation and shows
nuclear localization of Atx-1 puncta
(a) Overexpression of dmPI31 alone shows PI31 highly expressed to the giant glial cells in the
medulla. This staining overlaps with the nervana2 Gal4 driven expression of GFP. (b) Lines
expressing hAtx-1[82Q] alone show marked accumulation of Atx-1 signal that can be suppressed
with (c) co-expression of dmPI31.
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4.4 Discussion
Spinocerebellar Ataxia Type-1 is a neurodegenerative polyglutamine disease that is
characterized by the accumulation of mutant ataxin-1 into nuclear inclusions positive for
UPS components and chaperones. The pathogenesis of disease has also been show to display
aberrant proteasome function (Cummings et al., 1998; Park et al., 2005). Here, it is shown
that dmPI31, an essential proteasome regulator, suppresses degenerative phenotypes
associated with the disease. Overexpression of DmPI31 increases the degradation of
polyubiquitinated proteins but the exact mechanisms by through which it acts to suppress
degeneration remains to be shown. Interestingly, the truncated PI31DHbYX shows greater
suppression of degenerative phenotypes leading to questions how DmPI31 acts to regulate
the UPS in this context. This is especially relevant since both mutant and wild-type ataxin-1
are ubiquitinated at similar rates in vitro but the mutant protein remains highly resistant to
degradation (Cummings et al., 1999). To determine what may contribute to these difference,
preliminary results show that proteasome assembly is not significantly impacted while
pointing toward local proteasome activity as being important. DmPI31 and the HbYX deleted
protein have different subcellular localizations in a model for Parkinson’s disease but their
localization in the SCA1 model remain to be resolved. Still, these results show that driving
DmPI31 expression suppresses the accumulation of ataxin-1 in vivo. Further studies are
needed to determine how PI31DHbYX acts on these puncta and whether cytoplasmic or
nuclear proteasome activity is more critical.
Also, whether or not this suppression is due to a functional NAD+ salvage pathway
remains to be shown. Previous reports show that overexpression of Nmnat, an essential
NAD+ salvage enzyme, was sufficient to suppress degeneration in SCA1. In addition, the
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enzymatically inactive form also offered mild suppression (Zhai et al., 2008). The yeast
homologs of NMNAT, NMA1 and NMA2, were also able to suppress proteotoxicity in
neurodegenerative models of disease but interestingly other components of the NAD+
salvage pathway such as QNS1, PNC1, and NPT1 also protected. Disruption of NPT1 in an
NMA1 or NMA2 overexpression background still suppressed toxicity caused by 103Q
suggesting a functional salvage pathway is not needed. However, these results don’t negate
the presence of compensatory pathways for NAD+ biosynthesis or the idea of parallel
pathways mediating both chaperone and UPS activity as essential. The preliminary results
that were gathered here showed a slight decrease in polyubiquitinated proteins in flies fed for
5 days on 20mM Na but whether or not this suppression relies on DmPI31 remains to be
determined. Also, whether further clearance can be achieved in flies overexpressing DmPI31
and under NAD+ repletion may implicate modification of DmPI31 as essential for increased
proteasome activity under stress. To test this, DmPI31DHbYX transgenic lines can be subject
to NAD+ repletion and the amount of cleared polyubiquitinated proteins compared to full
length DmPI31.
These findings hint at a pathway with the ability to suppress the pathogenesis of SCA1
that may also translate to improving proteotoxicity in other polyglutamine diseases. The
exact mechanism by which toxicity is suppressed with overexpression of DmPI31 remains to
be determined. It is intriguing, however, to envision a means by which neurons may be able
to localize proteasome activity by differential modification of the proteasome regulator,
DmPI31.
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4.5 Materials and Methods
Fly stocks and culturing
Drosophila SCA1 models for hAtx-1[82Q] on the X (39740) and 3rd chromosomes (33818) were
obtained from Bloomington along with UAS-Atx-1 (39741). All other lines used in this chapter
are previously described in other sections.

Crytostat sections of Drosophila heads
Frozen sections were taken according to the following protocol (Helfrich-Förster, 2007).Working
quickly, whole heads from indicated genotypes are removed from body and proboscis is
removed. These heads are placed in 4% PFA overnight at 4°C and washed 3X the next day in
PBST. Heads are then subject to a sucrose gradient 5%, 10%, 25% sucrose. Heads were allowed
to sink and then transferred to OCT medium in a cryostat chuck that was then quickly frozen by
dipping into a dry ice/ethanol bath. Section were kept at -80°C until reading to section at which
time 10um sections were taken. Ribbons of sections were placed on glass slides and fixed for an
additional 10min in 4% PFA, washed 3X, blocked with 2% BSA, and immunostained with
primary antibody on top of glass slides with plastic coverslips. Primary antibodies a-chaoptin
(1:100, 24b10 DSHB), a-RH1 (1:100, 4C5 DSHB), Donkey a-rabbit-HA (1:1000). Images were
taken on confocal microscope.

Whole mount retinal dissections and immunostaining
Protocol from (Hsiao et al., 2012) was followed for the dissection of whole mount retinae.
Briefly, retinae were carefully removed from adult heads and placed in 4% PFA for 40min on
ice. At this point it is crucial to remove the lamina very carefully and wash retina 3X in PBST.
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Primary antibody staining is done in PCR tubes to reduce volume. The following antibodies were
used a-armadillo (1:100, N27A1 DSHB) and Alexa Fluor 647 Phallodin from CST (1:500).
Washed 3X and incubated with secondary antibody a-mouse FITC (1:500) before another wash
and mounting by preparing ‘bridges’ so that retina are not folded while imaging.

Whole mount brain dissections and immunostaining
Whole mount brain dissections are done in the same manner as in Chapter 2. Here however, FK2
antibody was used at (1:500) and a-HA rabbit (1:500). Alpha2GFP brains were also dissected
and stained for FK2. Images were quantified using ImageJ by measuring the corrected
fluorescence intensity. Human ataxin-1 antibody was obtained from Cell Signaling (2177S) and
used at dilution (1:200).

Western blots
Head only lysates were homogenized in lysis buffer (20 mM HEPES-KOH [pH 7.6], 200 mM
KCl, 0.5mM EDTA, 10% glycerol, 1% Triton X-100 and protease inhibitor cocktail [Complete;
Roche]) and spun in a microcentrifuge for 15min at 4°C. Protein concentration was measured
using BCA assay and normalized. 45ug protein was added along with 1X SDS sample buffer and
proteins were resolved for 1.5hour at 100V in 4-20% precast gels. Transfer was done at 4°C for
1.2 hours at 100V using PVDF membranes and tris-glycine buffer plus 20% methanol. After
transfer, membrane was blocked and primary antibodies were incubated each for 1 hour. The
same membrane was stripped and blocked between each antibody. Anti-Ataxin-1 (1:500), aalpha7 (1:500), a-PI31 generated in the lab by Yetis Gultekin (1:2500), and a-tubulin (1:2500)
were used.
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Native gels
Preliminary native gel analysis was run on heads collected from the indicated genotypes in the
same fashion as in Chapter 3.

111

5. Future Perspectives
5.1 Insights into the in vivo function of DmPI31
Several in vivo functions of DmPI31 in Drosophila neurons were uncovered in this study
including maintenance of AZs, motor neuron morphology, and photoreceptor axons. However,
results from this study imply that DmPI31 also has developmental roles in maintaining
proteasome activity to regulate degradation of cell cycle components. Yet, the cause of lethality
of dmPI31 mutants remains to be uncovered. The expansion of Dpn positive cells within the
larval brain point to serious defects in cell cycle control that could lead to apoptosis and a simple
way to test this hypothesis is by TUNEL assay since cleaved DCP-1 showed a slight
accumulation. However, the post mitotic effects of loss of DmPI31 remain of major interest as it
still remains to be seen whether the primary mechanism by which DmPI31 acts to regulate
proteasome activity is through increased assembly. Global changes in proteasome assembly from
whole head lysates show increased assembly upon NAD+ repletion that was dependent on
DmPI31 but ADP-ribosylated DmPI31 was not detected in adult flies. However, these
modification may be small compared to the global changes and may not reflect the amount of
proteasome regulation going on at particular locales, such as at the synapse. Thus, looking into
DmPI31 localization may provide critical insight into its major function as a proteasome
regulator. Indeed, ongoing studies in our lab point to DmPI31 being a direct transporter of
proteasomes to distal parts of the axon. However, how this movement is regulated, what prompts
the movement of proteasomes, and whether movement relies on ADP-ribosylation is still
unclear.
In addition, an understanding of how DmPI31 itself is regulated will provide key insights
into when this protein may be active. From the data presented in this thesis it is clear that
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DmPI31 can be regulated by nutritional status but whether this occurs as a result of posttranslational modification or transcriptional regulation was not resolved. Uncovering
transcription factors that may act on DmPI31 could provide insight into when this protein is
active. Whether PI31 binding to the proteasome is also still unknown. How can this protein with
an intact HbYX motif bind to 20S and still activate 26S? It is possible that modification of
DmPI31 results in cleavage of the C-terminal end of this protein to relieve 20S inhibition in vivo
but the N-terminal end maintains interaction with 26S and aids in its stability. Cleavage of
DmPI31 C-terminus is under active investigation in our lab and previously reported to be
involved in its stability (Bader et al., 2011).

5.2 Changes in NAD+ metabolism with age and declining proteostasis
Both NAD+ levels and proteasome assembly have been shown to decline with age which
makes for an intriguing hypothesis about why many neurodegenerative diseases are late-onset. A
decline in NAD+ could lead to a steady decline in proteostasis with age leading to
neurodegeneration. Indeed, these studies give attention to this hypothesis, as I show that NAD+
leads to increased proteasome activity. Others have shown that boosting NAD+ levels can
suppress neurodegeneration and here I have shown that NAD+ repletion can suppress the
accumulation of polyubiquitinated proteins. However, the direct mechanism of these
observations remains to be uncovered. NAD+ is involved in a variety of cellular processes
including the production of ATP, thus it is possible that maintenance of neurons by proteasome
activity is an indirect effect of more ATP production. Whether this increase proteasome activity
by NAD+ is dependent on ADP-ribosylated PI31 is currently being explored, but small amounts
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the of ADP-ribosylated form only in distinct compartment may prove uncovering a mechanism
challenging.
Although Nmnat can rescue neurodegeneration independent of its NAD+ synthase
activity, it does not rule out that increased NAD+ does not further suppress phenotypes. Thus it
would be interesting to see whether overexpression of Nmnat in combination with
overexpression of DmPI31 or upon NAD+ repletion can further suppress the phenotypes caused
in the Drosophila SCA1 model. Parallel pathways are likely to exist that mediate neuronal health
via maintenance of proteostasis since loss of proteostasis is detrimental.
Parallel pathways, NAD+ supplements, neuronal health via maintenance of proteostasis

5.3 DmPI31-mediated proteasome regulation in maintaining neuronal health
The cumulative results of these studies show that DmPI31, an essential proteasome regulator, has
the ability to directly affect proteasome activity in vivo. The role of DmPI31 and the reported and
implied post-translational modifications that it undergoes make it an excellent candidate for
small molecule compounds that could regulate proteasome activity under certain conditions.
Bortezomib, a proteasome inhibitor, inactivates proteasomes globally and thus results in the
unwanted side effect of peripheral neuropathy. However, targeting PI31 may bypass these effects
depending upon the post-translation modification that is targeted.
It is becoming apparent that DmPI31 may play an essential role is proteasome localization
from my work and other work in the lab. What is interesting is that neurons may use DmPI31 to
move proteasomes to required compartments in addition to them functioning to properly
assemble proteasomes. The location of endogenous DmPI31 in photoreceptor axons implies that
a mechanism exists to transport proteasomes to these distant compartments. Once their
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destination is reached, subcellular NAD+ pools could act to increase proteasome assembly at
these distinct locations, and this mechanism could function to maintain synapses and promote
neuronal health. New tools that are being developed will allow for identification of subcellular
NAD+ pools in vivo which will guide our understanding of where ADP-ribosylation of DmPI31
is likely having the most benefit. The whole story about how DmPI31 acts on proteasome
activity is still to be clear up but ultimately will lead to a better understanding of how
proteostasis is maintained throughout the aging processes in neurons and will open the field up to
explore 26S proteasome regulation even further.
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